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Some 1 million people in the Netherlands suffer from chronic pulmonary diseases. These chronic 
diseases impose a great burden on patients, caregivers and society, and are associated with 
many day to day problems. Of these, lack of physical activity is explored in more detail in this 
thesis, expecially focussing on COPD.
Chronic obstructive pulmorary disease
Chronic obstructive pulmorary disease (COPD) is defined in 2017 by the Global Initiative for 
Chronic Obstructive Pulmonary Disease as follows:
“Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, 
is characterized by persistent airflow limitation that is usually progressive and associated with an 
enhanced chronic inflammation response in the airways and the lung to noxious particles or gases. 
Exacerbations and comorbidities contribute to the overall severity in individual patients.” (1)
Patients with COPD often suffer from symptoms like cough, phlegm, dyspnoea, decreased 
exercise tolerance, possibly resulting in exacerbations and low health-related quality of life. 
Patients increasingly experience problems in their daily living as the disease progresses to more 
advanced stages (1). One of the most common symptoms of COPD is shortness of breath or 
dyspnoea, and most specifically on exertion. Dyspnoea can be induced by every day tasks. 
As a consequence of dyspnoea patients with COPD may avoid daily physical activities and 
therefore may enter a downward spiral of symptom-induced immobility leading to lack of fitness, 
depression and social isolation (1).
The classification of COPD used to be based only on severity of airflow limitation, divided in 
four categories of severity (GOLD I-IV) according to the degree of airflow limitation measured 
with spirometry. Recently, the classification of COPD severity has been extended; new GOLD 
guidelines now grade patients (GOLD A-D) based on symptoms, airflow obstruction, and 
exacerbation history (1).
COPD cannot be cured; however management of COPD can limit the disease progression, 
reduce symptoms and exacerbation frequency, improve health status and quality of life, and 
possibly reduce mortality. The management of COPD consists of four components: 1) assess and 
monitor disease; 2) reduce risk factors; 3) manage stable COPD and 4) manage exacerbations. 
The management of COPD differs per stage but also per patient. In the first stages of the 
disease, management involves the prevention of disease progression by the avoidance of risk 
factors and pharmacotherapy to control symptoms. As the disease progresses, patients with 
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COPD often require an expansion of the treatment options like pulmonary rehabilitation, long-
term oxygen therapy, surgical treatment or lung transplantation (1).
Pulmonary rehabilitation has been shown to reduce breathlessness, increase exercise capacity, 
and to improve health related quality of life (2). Although pulmonary rehabilitation is an effective 
strategy in reconditioning of patients with COPD, there is a considerable loss of effect in a 
relatively short period of time (6 months) (3). This loss of effect was also shown after long term 
home rehabilitation (4).
An important focus and outcome of pulmonary rehabilitation should be the enhancement 
or maintenance of daily physical activity. However, in most rehabilitation programmes daily 
physical activity is not a primary outcome, even though a physically active lifestyle is a predictor 
of pulmonary function and health related quality of life (2;5). Furthermore, there are strong 
indications that daily physical activity has significant implications for disease progression, 
systemic inflammation, and quality of life in COPD (6-8). It has been shown that patients with 
COPD who are regularly physically active have a lower risk of both COPD related hospital 
admissions and mortality (9). Despite the high prevalence of COPD there is little information 
about the daily physical activity level of patients with COPD in various stages of their disease 
(10;11).
Physical activity
Physical activity can be defined as ‘any bodily movement produced by the skeletal muscles that 
requires energy expenditure’. This includes all movements in everyday life, including work, 
recreation, exercise and sporting activities (12). Regular physical activity supports overall 
physical and psychosocial health and fitness, and contributes to the primary and secondary 
prevention of several chronic diseases (13).
Physical activity guidelines
To maintain fitness in adults, the American College of Sports Medicine (ACSM) states that 
a minimum of 30 minutes of physical activity of moderate intensity, is necessary on top of 
instrumental activity of daily living (14). The level of physical activity can also be expressed 
in a number of steps taken per day. Recommendations for healthy adults are to walk 10.000 
steps per day. The number of steps per day is thought to reflect the level of daily physical 
activity: sedentary (<5,000), low-active (5,000–7,499), somewhat active (7,500–9,999), active 









There are several different measurement tools to assess daily physical activity (Table 1). 
Performance based instruments, questionnaires and interviews provide different, yet 
complementary information.
 
Table 1. Instruments to assess daily physical activity
Instrument Description Advantage Disadvantage
Interview Everything concerning 
the main subject can be 
discussed
Time consuming
Obtained data is difficult 
to compare with each 
other.
Questionnaires Quantification of daily 
physical activities during 
a fixed recall period
Can be used in a large 
group
Attendance for wishful 
answers





record the total number 
of steps per day
Multi-axial 
accelerometers also 
record intensity of 




High validity, also in older 
subjects and chronic 
diseases
Upper-extremity and 
static activities are not 
measured
No specific information 
is recorded about the 
type of activity
Expensive
An extensive review on how to measure physical activity in COPD concluded that the selection 
of which instrument to use for quantification of physical activity in daily life should depend mainly 
on the purpose of its use (16).
Accurate measurement, monitoring, as well as treatment of the daily physical activities of 
patients with COPD may be relevant for the prevention of the above-described downward 
spiral of symptom-induced inactivity.
Enhancing daily physical activity
To prevent or reverse the downward spiral of inactivity it is probably important to prevent 
the decrease in daily physical activity or even to enhance it. The physical activity goals from 
guidelines for healthy adults, a minimum of 30 minutes of physical activity of moderate intensity 
on top of instrumental activity of daily living, might not be feasible for all patients with COPD. 
Physical activities of moderate intensity can cause dyspnoea in patients with COPD. Also, muscle 
deconditioning and muscle fatigue are frequently present in patients with COPD. Consequently, 
patients with COPD often avoid moderate intense physical activities.
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There are no current guidelines for the enhancement of physical activity in COPD. Due to the 
increase of symptoms as the disease progresses, one single guideline might not be feasible. 
Enhancing physical activity in patients with COPD requires an individualized or tailored 
approach. In healthy older adults, enhancement of low-to-moderate-intensity physical activity 
has been proven to be effective in strengthening health-related fitness and quality of life (17;18). 
Low to moderate intensity physical activities, like daily physical activities such as walking at 
moderate pace, also have been proven to enhance physical fitness in patients with COPD (19).
To monitor (enhancement of) daily physical activity pedometers have been shown to be effective 
in healthy people as well as in various patient groups (20-23). Pedometers are not only useful 
monitoring instruments of daily physical activity, but are also relevant in triggering enhancement 
of daily physical activity (24-27). Besides monitoring daily physical activity, individual goal setting 
has been shown to be effective in enhancing daily physical activity (28). A combination of these 
techniques might be effective in enhancing daily physical activity in patients with COPD.
Determinants of daily physical activity in COPD
For healthy subjects a lower level of daily physical activity is associated with higher age, 
being female, lower socio-economic status, and higher body-mass index (29). In patients with 
COPD, disease specific factors such as decreased pulmonary function, dyspoea, decreased 
exercise tolerance, exacerbations and low health-related quality of life could also play a role 
in determining the level of physical activity. The question arises if the physical activity level 
of patients with severe COPD is greatly affected by disease specific factors, next to ‘normal’ 
psychosocial factors like motivation to be physically active.
Another important determinant of physical activity in COPD might be sleep quality and sleep 
timing. Sleep abnormalities are common in patients with obstructive airway diseases like asthma 
and COPD. These abnormalities have been attributed to respiratory symptoms (cough, sputum 
production, wheezing), nocturnal oxygen desaturation, hypercapnia, and circadian changes 
in airway caliber and resistance, and side effects of medications (30). In asthma, the worst 
symptoms generally occur in the early morning hours. In many asthma and COPD patients, a 
combination of the mentioned abnormalities could contribute to sleep disruption. Disruptions in 
sleep could also affect the amount of physical activity during the day and the perceived quality 
of life (31). To examine sleep problems it is relevant to register disruptions in the sleep/wake 
cycle and movements during the night. The measurement of body movement during rest is not 
commenly used in research.
The preferred timing of the sleep-wake rhythm is described in chronotypes. Chronotypes 








genetics (32). Early types are more likely to have earlier bedtimes, sleep midpoints, and wake 
times. Late chronotypes are more likely to have late bedtimes, sleep midpoints, and wake 
times. Not surprisingly, there is a large interindividual variation in chronotypes (32;33). Late 
types report psychological and psychosomatic disturbance more often than do early types and 
experience more mental exhaustion in the evening. Depressed moods shows a high incidence 
in particularly late chronotypes, and late chronotypes consume more stimulants (alcohol and 
coffee) and are more often habitual smokers than are early types (34;35). For all chronotypes, 
the amount of time spent outdoors in broad daylight significantly affects the timing of sleep (32). 
A low level of daily physical activity could be related to little time spent outside in the daylight; 
in other words the level of daily physical activity could be related to one’s chronotype.
Daily physical activity in patients with COPD after lung transplantation
Lung transplantation is a treatment option to be considered in those patients with end-stage 
COPD for whom an alternative treatment modality is no longer available (36;37). To assess the 
effects of lung transplantation, survival, pulmonary function, physical fitness and health-related 
quality of life before and after lung transplantation are frequently compared (38).
After lung transplantation, pulmonary functioning is significantly improved. However, 
physical fitness frequently remains diminished due to peripheral muscle limitations after lung 
transplantation (37;39;40). Peripheral muscle force may be limited due to post-transplantation 
factors such as immunosuppressive medication, which might affect both skeletal muscles and the 
cardiovascular system (41). Despite this limitation in physical fitness, lung transplant recipients 
have shown significant improvements on the physical functioning scale of health related quality 
of life questionnaires (42-44). Consequently, the question rises whether lung transplantation 
actually improves the level of daily physical activity in patients with COPD. As daily physical 
activity probably is relevant for the perception of patient’s quality of life, it might be another 
clinically important outcome variable of lung transplantation.
Obesity after lung transplantation
After lung transplantation, overweight or obesity (body mass index (BMI) >25 kg/m2) is 
present in 30 percent of the living lung transplant recipients of the University Medical Center 
Groningen. Overweight and obesity-related diseases such as type II diabetes, hypertension 
and cardiovascular disorders affect post lung transplantation survival (45-49). In the general 
population, the principal factors for developing overweight and obesity are limited physical 
activity, excessive food intake and low resting energy expenditure (50-53). In lung transplant 
recipients, there is only scarce information about the contributing factors of the development of 
overweight. Ongoing administration of immunosuppressive therapy is associated with (steroid) 
myopathy and reduced skeletal muscle function in lung transplant recipients. Consequently this 
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may in the long term lead to limited exercise capacity (54-58), reduced daily physical activity, 
and reduced energy expenditure. Ongoing corticosteroid intake may also stimulate appetite 
and lead to increased BMI, as demonstrated in kidney and heart transplant recipients (59;60). A 
decreased resting energy expenditure may theoretically also contribute to increased BMI, as was 
shown in liver transplant recipients (61). To prevent or to treat the development of overweight, 
we believe it is very important to understand the underlying factors and their relationship.
AIM OF THE THESIS
The overall aim of this thesis is to examine daily physical activity in patients with COPD and to 
determine which determinants contribute to the variation in the level of daily physical activity 
in patients with a pulmonary disease, especially COPD.
AIMS
To examine:
1. the level of daily physical activity in COPD (Chapter 2 & 3)
2. the enhancement of daily physical activity in COPD (Chapter 4)
3. the level of daily physical activity in COPD after lung transplantation (Chapter 5 & 6)
4. the determinants of daily physical activity in COPD (Chapter 2-6)
5. sleep timing and sleep quality in relation to daily physical activity in patients with obstructive 
airway diseases (Chapter 7 & 8)
Chapter 2 Daily physical activity in patients with COPD; a review
In this chapter we perform a systematic review of the literature on the level, intensity and type 
of physical activity in patients with COPD as compared to controls, taking into account the 
whole range of physical activities (household-, sports-, leisure time- and work-related physical 
activity), assessed with performance-based as well as self-reported instruments. Furthermore, 
Chapter 2 focuses on the relationship of daily physical activity with pulmonary function, physical 
fitness, systemic inflammation and quality of life. Further insight in the amount and determinants 
of daily physical activity of patients with COPD could provide important clues to promote daily 
physical activity.
Chapter 3 Determinants of daily physical activity in patients with COPD
Variables reflecting functional capacity as well as psychological variables may influence daily 
physical activity. Accurate insight in these determinants of daily physical activity of patients with 
COPD may be relevant for the prevention of the downward spiral of symptom-induced immobility. 








variables in patients with COPD recruited from the primary (general practitioner), secondary 
(hospital outpatient clinic) and tertiary (pulmonary rehabilitation centre) healthcare setting.
Chapter 4 Enhancing daily physical activity in patients with COPD
In chapter 4 the enhancement of daily physical activity in patients with COPD is examined by a 
behavioral modification strategy, including a lifestyle physical activity counseling program with 
feedback of a pedometer. In chapter 4 we hypothesize that an individual exercise counseling 
program combined with a pedometer is a feasible and effective method to increase daily physical 
activities like walking, cycling, stair-climbing and gardening in out clinic patients with COPD.
Chapter 5 Daily physical activity in lung transplant patients
In chapter 5, the daily physical activity status of COPD lung transplant patients in relation 
to pulmonary function, physical fitness, fear of physical activity and motivation to exercise 
is examined. We hypothesize that lung transplant recipients as compared to lung transplant 
candidates show a higher level of daily physical activity, physical fitness, are more motivated to 
move and have less fear of movement.
Chapter 6 Obesity and overweight in lung transplant patients
In chapter 6 we examine the possible determinants of large increases in weight after lung 
transplantation. The role of daily physical activity, resting energy expenditure and daily food 
intake is examined in lung transplant recipients with the most prevalent underlying lung 
conditions; COPD and lung fibrosis.
Chapter 7 Sleep timing in asthma and COPD patients
In chapter 7 we examine the variation of midsleep and chronotype distribution between 
asthma and COPD compared to a large general control group. Furthermore the association 
of chronotypes with severity/control of disease, nocturnal complaints, sleep quality, physical 
activity, smoking, and medication is assessed within asthma and COPD patients.
Chapter 8 Validation of the Dynaport MiniMod during Sleep
In chapter 8 we examine the feasibility and validity of 3-axial accelerometer (DynaPort MiniMod) 
in accessing body posture and physical activity during sleep. Study A focuses on the correlation 
between the movement times measured by the DynaPort MiniMod and the Actiwatch and Study 
B focusses on the correlation between the posture registration of the DynaPort MiniMod and 
polysomnography.
Chapter 9 Summary, Discussion and Future Perspectives
In chapter 9, the results of the studies are summarized and put in to perspective.
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ABSTRACT
Patients with chronic obstructive pulmonary disease (COPD) are often limited in their daily 
physical activity. However, the level, type and intensity of daily physical activity are not known, 
nor there is a clear insight in the contributing factors. The aim of this review is to describe daily 
physical activity of COPD patients, and to examine its relationship with demographic factors, 
pulmonary function, physical fitness, systemic inflammation and quality of life. A systematic 
literature search was conducted, including studies assessing daily physical activity in all stages 
of COPD by various different types of measurement techniques. In total 47 studies were 
selected; 17 performance-, 20 questionnaire-, and 12 interview-based. Two studies used 
both a performance- and questionnaire-based method. Overall, COPD patients have a lower 
level and intensity of daily physical activity compared to healthy controls. This was reported 
by performance- as well as questionnaire-based studies, yet with a large variation (42-86% 
and 28-97%, respectively). Reduced daily physical activity is associated with higher levels of 
airway obstruction, higher levels of systemic inflammation, and lower levels of physical fitness. 
The association between daily physical activity and quality of life is less clear. In conclusion, this 
is the first review that examined the level, type and determinants of daily physical activity in 
COPD. It demonstrates that reduced daily physical activity frequently occurs in COPD patients, 




Daily physical activity can be defined as the actual level of physical performance one adopts 
in daily living (1). For healthy subjects a lower level of daily physical activity is associated with 
higher age, being female, lower socio-economic status, and higher body-mass index (2). Daily 
physical activity is related to, but not synonymous with functional capacity status. Functional 
capacity is defined as the maximal performance potential of an individual, usually determined 
by physical fitness and limited by disease-related impairments such as dyspnoea (1). COPD 
patients frequently report dyspnoea induced by daily physical activity. Consequently, patients 
with COPD may avoid daily physical activity and end up in a downward spiral of symptom-
induced immobility leading to a decrease of muscle strength and endurance, social isolation and 
depression (3). Accurate measurement, monitoring, as well as treatment of the daily physical 
activities of patients with COPD may be relevant for the prevention of this downward spiral of 
symptom-induced immobility.
A method to assess daily physical activity level in COPD patients is by questionnaires, which 
enquires patients to quantify their daily physical activities during a fixed recall period. Possible 
disadvantages of this method are the attendance for wishful answers or presence of a recall 
bias (4). Another method to assess daily physical activity is by interviews. The advantage of 
this method is that everything concerning the main subject can be discussed because the 
participants are encouraged to talk freely. Possible disadvantages are that this method is time 
consuming and retrieved data is difficult to compare with each other. Nowadays, daily physical 
activity in COPD patients is increasingly measured by accelerometers or pedometers. These 
devices assess daily physical activity in a performance-based way. Uni-axial pedometers are 
able to record the total number of steps per day, while multi-axial accelerometers also record 
intensity of physical activity and energy expenditure. Possible disadvantages of performance-
based methods are that upper-extremity activities are not measured, and no specific information 
is recorded about the type of activity (5), while this might be especially important from the 
patients perspective. In contrast, this specific information could be assessed with questionnaires 
or interviews. Performance-based instruments, questionnaires and interviews provide different, 
yet complementary information.
There are strong indications that daily physical activity has significant implications for 
disease progression, systemic inflammation, and quality of life in COPD (6-8). For example, 
COPD patients who are regularly physically active have a lower risk of both COPD related 
hospital admissions and mortality (9). Further insight in the amount and determinants of daily 
physical activity of COPD patients could provide important clues to promote daily physical 








patients with COPD as compared to controls, taking into account the whole range of physical 
activities (household-, sports-, leisure time- and work-related physical activity), assessed with 
performance-based as well as self-reported instruments. Furthermore, this study focuses on 
the relationship of daily physical activity with pulmonary function, physical fitness, systemic 
inflammation and quality of life.
METHODS
Data sources and search strategy
Studies were included in which movement detection devices, questionnaires and structured, 
semi-structured or unstructured interviews were used to assess daily physical activity. To 
detect these studies, a literature search was carried out using Pubmed (MEDLINE), CINAHL 
and Cochrane, and relevant references were checked in the selected articles. Studies between 
1995 and 2009 were selected. Main inclusion criteria were chronic obstructive pulmonary disease 
(GOLD stage I to IV) and assessment of daily physical activity.
We excluded intervention studies without information about baseline daily physical activity, 
studies without a clear description of the daily physical activity measurement, studies without a 
measure of lung function (except for interview-based studies), and studies with healthy controls 
matched on daily physical activity level. Moreover, we did not include studies which used quality 
of life instruments to assess daily physical activity. There were no restrictions concerning sample 
size or study design. Language was limited to English. To select relevant literature about the 
level, type, and intensity of physical activities, we used the following keywords in combination 
with ‘COPD’: ‘physical activity’, ‘daily physical activity’, ‘activities of daily living’, ‘pedometer’, 
‘accelerometer’, ‘physical activity questionnaire’ and ‘interview’.
Selection of studies
All articles were independently selected for inclusion by two reviewers. If no consensus could 
be achieved between the two reviewers, a third reviewer was consulted. Studies were selected 
when 1) there was a description of the daily physical activity level of COPD compared to healthy, 
and/or 2) there was a description of daily physical activity type of COPD patients, and/or 3) 
there was an analysis of the determinants of daily physical activity.
Unlike randomized controlled trials, there are no lists of appropriate quality assessment for 
observational studies. In this review, the quality assessment of the studies was performed at the 
inclusion: Articles had to contain a measure of pulmonary function and a diagnosis of COPD, with 
exception of the interview-based. In all, the instrument used to measure daily physical activity 
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had to be described. In the selected articles including determinants of daily physical activity, 
the statistical analysis had to be described.
Figure 1. Flow chart of the inclusion process.
Data extraction
Information was extracted from the included studies and tabulated. The characteristics 
considered in each study were: patient characteristics (sample size, percentage of males, age 
and FEV
1
), daily physical activity method and outcomes, secondary outcome measures (FEV
1
, 
physical fitness, systemic inflammation and quality of life) and daily physical activity in relation 









Daily physical activity was divided into the categories performance-, questionnaire-, and 
interview-based. Per category, we examined the daily physical activity level of COPD patients 
compared to healthy controls. We examined the daily physical activity type, divided in two 
groups; activities that could or could not be performed anymore and activities that were difficult 
to perform. Next, we examined whether daily physical activity was related to measures of airflow 
obstruction, physical fitness, systemic inflammation and quality of life.
RESULTS
In total 47 studies were included (Figure 1). There were 752 studies found after database 
searching and other search strategies. Of these, 695 did not meet the inclusion criteria. Main 
exclusion criteria were the absence of a lung function measurement and the absence of a daily 
physical activity measure. After excluding articles, 47 studies remained for analysis. Daily 
physical activity was assessed in a performance-based way in 17 studies (Table 1-3); in a 
questionnaire-based way in 20 studies (Table 4-6) and in an interview-based way in 12 studies 
(Table 7). Two studies used both a performance- and questionnaire-based method.
Performance-based daily physical activity
Daily physical activity was assessed in a performance-based way in 17 studies (Tables 1-3). 
Different devices were used to assess the daily physical activity level. The most frequent used 
device was the DynaPort accelerometer (eight studies). The number of patients per study 
ranged between 10 and 170. When mentioned, the majority of patients were male. The mean 
age of the COPD patients was above sixty years, except for 2 studies.
Daily physical activity level
Daily physical activity in COPD patients was compared with healthy controls in a performance-
based way in 5 studies (Table 1). Out of these, 4 determined daily physical activity with an 
accelerometer and one study with a pedometer. The number of included patients ranged 
between 11 and 50, and was low overall. The mean age was above 55 years (mean age range 
COPD patients 56-67; Controls 53-70 years). The majority of the COPD patients was male in 
all 5 studies (total 78 males versus 35 females), while the healthy controls were more equally 
divided (total 48 males versus 41 females). The daily physical activity level of COPD patients 
compared to the healthy controls was significantly lower in all 5 studies (t-test and Mann-
Whitney U-test, all p<0.01). The intensity of physical activity was also significantly lower in 














































































































































































































































































































































































































































































































































































































































































































































































































































































healthy controls was set on 100%, the daily physical activity level of COPD patients expressed 
as a percentage of the daily physical activity level of healthy controls, was diminished to 57% 
(range studies 42-86%).
Daily physical activity type 
Seven studies quantified the type of daily physical activity in a performance-based way by using 
a DynaPort accelerometer and reported the outcomes in minutes per day (Table 2). One study 
compared mild to severe patients with healthy controls, revealing that COPD patients spend 
significantly less time on walking and standing, and show a higher sitting and lying time (11). In 
all studies, patients with COPD walk less than an hour a day. Inactive patients walked for less 
time and more slowly than active patients (t-test, p < 0.05) (15).
Daily physical activity determinants
Pulmonary function
Airflow limitation expressed as the percentage of predicted FEV
1
 ranged between 32-90% 
(Table 3). Seven studies determined a (baseline) association between daily physical activity 
and FEV
1
 (8;11;14;15;20-22). The correlations ranged between 0.28 and 0.62, all significant 
(p<0.01). One study reported a non-significant correlation between steps per day and FEV
1
 
(r=0.25, p-value not mentioned) (23). In one study inactive patients showed a lower mean FEV
1 
compared to the mean of
 
active patients (t-test, p<0.05) (15). One study reported significant 
main effect on steps per day from two-way ANOVA of GOLD stages (8).
Physical fitness 
Physical fitness was assessed in 8 performance-based studies (Table 3). As measurement tools 
of physical fitness, the 6-minute walk test (6MWT) (7 studies), quadriceps strength (3 studies), 
handgrip strength (3 studies), cycle ergometry (1 studies), and steady state exercise test (1study) 
were used. Five out of 7 studies using the 6-minute walk test, demonstrated a moderate to 
strong correlation with daily physical activity (range r=0.49-0.76, p< 0.002) (11;15;21;22;24). 
Two other studies reported no such association (10;23). Only one study reported a significant 
association between daily physical activity and muscle strength (r quadriceps= 0.45, p< 0.01, 
r handgrip= 0.44, p< 0.01) (11). Inactive patients showed a lower exercise tolerance compared 












































































































































































































































































































































































































































































































































































































































































































































































































































There were 2 performance-based studies focusing on systemic inflammation (Table 3). The first 
study found an association between reduced daily physical activity and higher values of systemic 
inflammation (high-sensitivity C-reactive protein and fibrogen), independent of GOLD stage 
or BODE-index (8). Another study demonstrated an inverse relation between daily physical 
activity and markers of systemic inflammation such as high-sensitivity C-reactive protein 
(r=-0.18, p=0.01), interleukin-6 (r=-0.23, p<0.001) and fibrinogen (r=-0.25, p<0.001) (25).
Quality of life
Quality of life was measured in 6 studies, using the Saint George Respiratory Questionnaire (4 
studies), the SF36 (2 studies), and the Chronic Respiratory Disease Questionnaire (2 studies) 
(Table 3). Two out of 4 studies using the Saint George Respiratory Questionnaire reported 
the results of their associations. One study reported a negative association between daily 
physical activity and quality of life (r=-0.28, p<0.01) (20), whereas the other study reported 
no association (10), One out of 2 studies using the SF36 reported that the physical subscale of 
the health status questionnaire was significant positively correlated with daily physical activity 
(r=0.40, p<0.001) (21), whereas correlation with the mental subscale was not (r=0.15, not 
significant) (21), One study using the Chronic Respiratory Disease Questionnaire reported a non 
significant correlation with daily physical activity (r=0.17, not significant) (21), The other study 
that used this questionnaire did not report any difference between inactive COPD patients and 
active COPD patients (groups based on compliance with the guideline: minimum of 30 minutes 
of walking per day) (15).
Questionnaire-based daily physical activity
Daily physical activity was assessed by various questionnaires in 20 studies (Tables 4-6). The 
most frequent used questionnaire was the Baecke Physical Questionnaire for the elderly 
(7 studies). The number of patients per study ranged between 9 and 3608. When mentioned, 
the majority of patients were male. The mean age of the COPD patients in the studies was above 
60 years, except for 2 studies.
Daily physical activity level
Daily physical activity in COPD patients was compared with healthy controls in a questionnaire-
based way in 7 studies (Table 4) (26-32). The number of included patients ranged between 9 
and 68, and was low overall. The mean age was above 58 years (mean age range COPD patients 
58-68; Controls 58-64 years). The male/female ratio was not mentioned in all studies, but when 
mentioned the majority of the COPD patients was male, except for 1 study (total 120 males 
versus 68 females), which also holds for healthy controls (total 115 males versus 86 females). The 
daily physical activity level of COPD patients compared to the healthy controls is significantly 
33
lower in 5 out of 7 studies (t-test, Fisher exact probability test, and Mann-Whitney U-test, all 
p<0.05) (26-29;32). In total, when the activity level of healthy controls was set on 100%, the 
daily physical activity level of COPD patients expressed as a percentage of the daily physical 
activity level of healthy controls, was diminished to 70% (range 28-97%).
Daily physical activity type
Daily physical activity type was assessed in a questionnaire-based way in 4 studies (Table 5). The 
activities that could not be performed anymore were: sports (27;33), work (27;34), and leisure-
time physical activities (27). Patients with a higher level of airflow obstruction (FEV
1
<50%) 
reported the worst dysfunction in everyday life, defined as walking, eating, home management 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Daily physical activity determinants
Pulmonary function
Airflow obstruction, measured by FEV
1
% predicted, ranged between 32% and 78% (Table 6). 
Eleven questionnaire-based studies reported on the relation with daily physical activity. Nine 
out of 11 studies reported an association between severity of disease and decrease of daily 
physical activity level (range r=0.10-0.63, p<0.05) (7;9;21;32;35-39). One study used 2 daily 
physical activity questionnaires with a high score representing inactivity and reported a negative 
correlation between outcomes of the daily physical activity questionnaires and FEV
1
% predicted 
(r=-0.11 and r=-0.72, p=0.001) (28). Two other studies did not demonstrate a (significant) 




Physical fitness was assessed in 8 studies (Table 6). Physical fitness was measured by the 
6-minute walk test (3 studies), cycle ergometry (3 studies,) quadriceps strength (4 studies), 
handgrip strength (2 studies), and arm strength (1 study). When measured with the 6MWT, 
one study showed that physically active patients perform better on the 6MWT test (7). One 
study reported a positive correlation (r=0.35, p<0.01) (21). When measured with cycle ergo 
meter, one study reported a positive correlation with daily physical activity (r=0.60, p<0.01) 
(32), whereas two other studies did not report a significant association (29;40). There was 
no significant association reported between quadriceps strength and daily physical activity. 
One study reported a positive non-significant correlation (r=0.04, NS) (32), one a negative 
correlation (r=-0.32, NS) (41), and two other reported no association (26;29).
Systemic inflammation
One questionnaire-based study focussed on systemic inflammation (Table 6). In this study, 
Garcia-Aymerich demonstrate that more physically active COPD patients have lower levels 
of systemic inflammation (TNF-α, interleukin-6, interleukin-8 and C-reactive protein) (7). No 
differences were found in body-composition and weight between the physical activity groups.
Quality of life
Quality of life was measured in 5 studies using the Chronic Respiratory Disease Questionnaire (2 
studies), the Clinical COPD Questionnaire (1 study), the Saint George Respiratory Questionnaire 
(1 studies), SF36/SF12 (1 study), and the Visual Analog Scale (1 study) (Table 6). Three studies 
demonstrated a significant positive association between daily physical activity and quality of life 
(total and individual domain scores) (range r= 0.17-0.48, p<0.01).(33;36;37) Whereas 1 study 
using 2 different quality of life questionnaires reported a non-significant negative association 
39
with daily physical activity (CRQ r=-0.21, NS; SF36 physical and mental subdomains r=-0.01 
and 0.02, NS) (21).
Interview-based type of daily physical activity
The type of daily physical activity was assessed by interview in 12 studies (Table 7). Most of 
these studies included small numbers of patients (range 6-100), apparently because the method 
is time consuming. Except for 2 studies, most patients were male. The mean age was above 60 
years. In all included studies the FEV
1
 (when mentioned) was below 50% predicted or disease 
state was described as ‘moderate to very severe’. Activities that could not be performed 
anymore are: everyday tasks (including self-care) (44), household activities (45;46), traveling 
(44;47), social activities (46-48), hobbies (47), sports (45), and work (45;48). The activities 
difficult to perform are: everyday tasks (including self-care) (45;49-52), household activities 
(49;52;53), leisure time activities such as walking (54), traveling (52;54), and sports (47). In 
general, females report more performance difficulties in home management tasks and hobbies. 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this study we systematically reviewed daily physical activity in COPD patients, categorized 
in performance-, questionnaire- and interview-based daily physical activity. The results 
demonstrate that daily physical activity for COPD patients is lower than in healthy controls 
and lower than what the international guidelines recommend to maintain or enhance physical 
health and fitness. This lower level of daily physical activity for COPD patients is associated 
with a higher level of airway obstruction, a lower level of physical fitness, and higher levels of 
systemic inflammation.
Daily physical activity level
The level of daily physical activity of COPD patients is about 57% (range studies 42-86%) of that 
of healthy age-matched controls in performance-based studies, and about 70% (range 28-97%) 
in questionnaire-based studies. These results demonstrate that there is a large range in the level 
of daily physical activity in COPD patients, even when measured with one and the same method. 
This large range could be due to different patient characteristics, different settings, and different 
measurement protocols. In this respect it should be noted that very few of the methods to assess 
daily physical activity, particularly the questionnaires, have been validated for COPD patients. 
From epidemiological type of studies it is well known that a large range in the daily physical 
activity level is quite usual in healthy as well as diseased subjects, even after adjusting for age 
and sex (2;20;56). An interesting observation of this review are the overall smaller differences 
in daily physical activity level of COPD patients compared to healthy controls, when assessed 
with a physical activity questionnaire than with performance-based measurement. Apparently, 
COPD patients are very well aware of accomplishing small routine daily activities that are not 
perceived by healthy controls. Another possible explanation is that COPD patients dissimulate 
their disease and give whisfull answers.
Determinants of daily physical activity level
This review demonstrates that in a large number of studies daily physical activity correlated 
positively with airway obstruction (7-9;11;14;15;20-22;32;35-39), 6-minute walk test 
(7;11;15;21;22;24), and muscle force (11;15). Although not all studies reported significant 
associations between daily physical activity and the secondary measurement, the studies that 
did, reported moderate to strong associations, especially those with airway obstruction and the 
6-minute walk test. Regarding the association with demographic factors it is well known that 
daily physical activity in healthy subjects diminishes with aging. This review confirmed this by a 
few studies reporting that higher age was indeed associated with lower daily physical activity 
level (7;33). A large questionnaire-based study on characteristics of COPD patients revealed 
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that a lower level of daily physical activity is significantly associated with female sex, older age, 
higher socioeconomic status, and lower physical as well as mental quality of life (33).
Daily physical activity and systemic inflammation
There are 3 studies focusing on daily physical activity in relation to systemic inflammation. All 3 
studies demonstrate that lower daily physical activity level is related to higher levels of systemic 
inflammation. Such relationships have also been demonstrated in healthy subjects and other 
chronic diseases (57-60). Whether reduced daily physical activity in COPD is cause rather than 
consequence of increased systemic inflammation remains unclear.
Daily physical activity level and quality of life
This review reveals that for COPD patients daily physical activity in a number of studies is 
significantly possitively correlated with health related quality of life (21;33;36;37). On the other 
hand, there were a few studies that reported a significantly negative association (20;21). An 
explanation for this discrepancy may be the use of different methods to assess daily physical 
activity and quality of life, difference between COPD populations, and low sample size. It 
is worthwhile to note that studies demonstrating a significant correlation frequently used 
questionnaire-based daily physical activity scores, whereas some of them also used a quality 
of life score that included questions directly related to daily physical activity. There were no 
positive correlations demonstrated in performance based studies. The absence of a clear 
relationship is in line with a previous systematic review on the effects of daily physical activity 
(61). An explanation for this maybe that many COPD patients during their slowly progressing 
disease gradually accept their sedentary life style. This finding is in line with large cross-sectional 
studies which demonstrate that perceived quality of life remains quite high in many COPD 
patients, even in the more severe disease stages (62;63). The same cross-sectional studies 
also demonstrate an enormous range of quality of life scores within different disease stages of 
COPD; so it might be that a proportion of COPD patients actually do not psychologically accept 
their disease state at all. This may, at least partly, explain the inconsistency of findings of the 
cross-sectional studies with respect to the positive correlation between daily physical activity 
and quality of life. Studies including this aspect of psychological adaptation are clearly needed 
to further support this.
Daily physical activity type
Not performed activities were mostly recreational and hobbies (walking and holidays), work, 
household, social, and everyday tasks (including self-care). Mostly reported difficulties 
to perform activities were: everyday tasks (including self-care), recreational and hobbies, 
household, and social. Interestingly, males and females withdraw their activities in a different 








difficulty in performing home management tasks and hobbies. This could mean that males and 
females should be treated in a different way when they participate in a physical enhancement 
or pulmonary rehabilitation program. The specific information about the types of daily physical 
activity that are being avoided and the order of withdrawal could have important implications 
for patient as well as physician. Not being able to perform certain types of physical activity, 
especially the types that reduce autonomy, may affect a patient’s quality of life.
Intervention studies targeting at daily physical activity
Interventions can be primarily targeted at increasing physical activities, theoretically followed 
by improvements of physical fitness. The usefulness of such a strategy is suggested by a meta-
analysis of Chavannes, which included 5 studies that targeted physical activities like walking, 
cycling, swimming and/or training of large muscle groups (61). One research group performed 
2 studies that used performance-based instruments in order to motivate COPD patients to 
increase their number of steps and other daily activities (64;65). Such a strategy is in line with a 
recent review on stimulation of daily physical activity in healthy and diseased subjects showing 
that pedometers can be very useful in the enhancement of daily physical activity. The effects of 
this enhancement are even larger when an individually based target was formulated using the 
goal setting technique (66). From these studies, it may be concluded that at least a subgroup of 
COPD patients may benefit from interventions that primarily target daily physical activity, yet 
such programs have to be tailored and further optimized.
Concluding remarks
The results of this review clearly demonstrate that the daily physical activity level in COPD 
patients is lower compared to healthy controls. This lower level of daily physical activity is 
associated with a higher level of airway obstruction, a lower level of physical fitness, and higher 
levels of systemic inflammation. There is no consensus on the association between a lower level 
of daily physical activity and quality of life.
Two important unmet needs have to be defined for future management and research:
1. Daily physical activity is an underestimated yet important outcome measure that should 
be measured routinely in the general management of COPD, and in observational and 
intervention studies.
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ABBREVIATIONS
COPD  Chronic Obstructive Pulmonary Disease
FEV
1
  Forced Expiratory Volume in 1 Second
SGRQ  Saint George Respiratory Questionnaire
6MWT  Six-Minute Walk Test
BMI  Body Mass Index
BMR  Basal Metabolic Rate
CCQ  Clinical COPD Questionnaire
CRP  C-reactive protein
CRQ  Chronic Respiratory Disease Questionnaire
EE  Energy Expenditure
FFMi  Fat-Free Mass index
Kcal  Kilo-calories
MET  Metabolic Equivalents
MRC  Medical Research Council
MVC  Maximal Voluntary Contraction
REE  Resting Energy Expenditure
TEE  Total Energy Expenditure
TNF  Tumor Necrosis Factor
VAS  Visual Analog Scale
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ABSTRACT
Background: Daily physical activity (DPA) level is reduced in patients with COPD. The aim of 
this study was to investigate the association of DPA with functional and psychological variables 
in these patients.
Methods: 155 COPD patients (102 males, median (IQR) age 62 years (54–69 years), predicted 
FEV1 60% (40–75%) were included. We assessed DPA (DigiWalker SW-200), functional 
capacity and psychological factors.
Results: DPA level was significantly associated with all functional capacity variables and two 
psychological variables (Perceived Physical Ability Subscale, depression subscale of the Hospital 
Anxiety and Depression Scale). The six-minute walking distance and St. George Respiratory 
Questionnaire activity score explained 37% of the variance of DPA in a regression analysis. 
A structural equations model revealed that psychological variables indirectly explained DPA 
through functional capacity variables. DPA was stronger associated with functional capacity 
variables and weaker with psychological variables in patients with lower functional status than 
in patients with higher functional status.
Conclusions: Higher levels of DPA are associated with better functional capacity, but 
interestingly, DPA is also affected by psychological factors, though only indirectly, via functional 
capacity. The effect of specific treatment addressing psychological factors on DPA level and 
exercise tolerance needs further investigation.
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INTRODUCTION
Patients with COPD may enter a vicious circle of reduced lung function, activity-induced 
dyspnea, immobilization, muscle deconditioning and muscle fatigue. In addition, psychosocial 
consequences like depression and social isolation may appear (www.goldcopd.com). This 
vicious circle may affect daily physical activity level (DPA) in COPD patients, assessed using 
accelerometers (1-6) pedometers (7-8). Lower DPA level is related to lower FEV1 (1-3, 7, 8), 
VO2peak (1, 4, 5) and 6MWD. In addition, a very low DPA level was associated with a higher 
risk for all-cause and respiratory mortality (9-12). The association of DPA with psychological 
variables such as anxiety, depression, self-efficacy and motivation has not been investigated 
extensively; depression was not associated with DPA level in two studies (6, 13), whereas self-
efficacy has been shown to correlate positively with DPA (3, 14). In addition, DPA counseling 
has been shown to improve intrinsic motivation for physical activity (15). We hypothesized 
that variables reflecting functional capacity as well as psychological variables influence DPA. 
In addition, we hypothesize that variables reflecting functional capacity affect DPA more in 
patients with a low functional status and psychological affect DPA more in patients with high 
functional status. To investigate this a broad group of COPD patients is included from the 
primary (general practitioner), secondary (hospital outpatient clinic) and tertiary (pulmonary 
rehabilitation centre) healthcare setting.
As we were interested in both direct and indirect relationships between DPA, functional and 
psychological variables, we performed, in contrast to previous studies (1-8), a path analysis 
using the structural equations modeling (SEM) technique, which allows estimation of direct and 
indirect associations of groups of variables.
METHODS
Subjects
Patients with stable COPD (n = 155) from seven general practices, four hospital outpatient 
clinics and one pulmonary rehabilitation centre were included. These patients participated in a 
controlled study of a physical activity counseling program. Inclusion criteria were diagnosis of 
COPD according to the GOLD criteria (16) and age between 40 and 80 years. Exclusion criteria 
were significant comorbidities interfering with physical activity and exacerbation or respiratory 
tract infection in the past two months. All patients signed a written informed consent. The study 
was approved by the local medical ethics committee of the University Medical Center Groningen 









Performance-based daily physical activity
Performance-based DPA (steps/day) was measured with the Digiwalker SW-200 pedometer 
(Yamax; Tokyo, Japan), which is an accurate measurement tool to detect steps taken (17), (18), 
(19) and (20). Patients were instructed to wear the pedometer during two weeks (from waking 
up until going to bed) and to record the number of steps per day in a diary. The mean of the last 
week of steps was used for further analyses. Data from this week were only used when more 
than 5 days of 7 were filled out.
Physiological characteristics
Weight, height and fat-free mass were measured, the latter by a bioelectrical impedance analysis 
(Bodystat 1500) (21).
Functional capacity
Performance-based functional capacity was assessed by lung function using a spirometer 
(Jaeger MS-IOS) and body plethysmograph (Masterlab version 4.52i) according to standardized 
guidelines (22). Reference values used were those of the European Community for Coal and 
Steel (22). The six-minute walking distance (6MWD) was used to assess functional exercise 
capacity and was performed in accordance with international standards (23).
Self-reported functional capacity was assessed by multiple questionnaires. Independent 
functioning in daily living was assessed by the Groningen Activity Restriction Scale (GARS) 
(24). Disease specific health-related quality of life was assessed by the St. George Respiratory 
Questionnaire (SGRQ) (25). The domains of this questionnaire containing items about functional 
capacity (activity and impacts scales) were selected for further analysis. Health status was 
assessed by the Short Form 36 (SF-36) (general) and Clinical COPD Questionnaire (CCQ) 
(disease specific) (26,27). The physical functioning scale (SF-36) and functional status scale 
(CCQ) were used for further analysis. Fatigue due to daily activities in household, body care 
and social activities were measured with the Dutch Exertion and Fatigue Scale (DEFS) (28).
Psychological capacity
Anxiety and depression were measured with the Hospital Anxiety and Depression Scale 
(HADS) (29). Self-efficacy was measured by the Perceived Physical Ability Subscale (PPAS) of 
the physical self-efficacy scale (30).
The level of intrinsic motivation for physical activity was measured using the Self-Regulation 
Questionnaire for Exercise (SRQ-E). This questionnaire deals with the reason why a person 
engages in physical activities and is based on the format of Ryan and Connell (31).
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Statistical analysis
Univariate and multivariate analysis
Because of non-normal distribution of the primary outcome measure steps/day, Spearman’s 
correlations of DPA with psychological and functional variables were calculated in the total 
group and in 2 subgroups based on functional status measured by the 6MWD (split by the 
median of 6MWD).
Multiple linear regression models (method stepwise) were constructed including 1) all 
variables (functional and psychological) that correlated significantly with steps/day, and 2) 
only psychological variables (anxiety, depression, self-efficacy and motivation). These statistical 
analyses were performed using Scientific Package of Social Sciences (SPSS) version 18.0. To 
test the null hypothesis alpha was set at 0.05.
Structural equations model 
A path analysis (LISREL 8.7) was used to test the hypothesized model, in which the direct effects 
of functional variables on DPA and simultaneously the indirect effects of psychological variables 
on DPA mediated through functional variables were estimated.
In this model latent constructs were conceptualized by ‘DPA’, ‘functional capacity’ and 
‘psychological capacity’. DPA was a latent construct estimated by taking the natural logarithm 
of steps/day. Indicators of the latent construct ‘functional capacity’ were performance-
based (FEV1, 6MWD) and self-reported (GARS, SGRQ activity and impacts, SF-36 physical 
functioning, CCQ functional and DEFS) functional capacity. The latent construct ‘psychological 
capacity’ was indicated by HADS anxiety, HADS depression, SRQ-E and PPAS. Variables were 
chosen based on their significant correlation with DPA in the univariate analysis or because they 
were thought to be interesting from a theoretical point of view. Of the lung function variables 
only FEV1 was used, and not RV%TLC because both variables were highly associated with 
each other, but FEV1 had a higher correlation with DPA. To allow for mutual comparisons 
between path coefficients, the completely standardized solution was used. For model fit we 
used multiple criteria as suggested by Bentler and Bonett (32). The first criterion used for 
model fit is a non-significant χ2 indicating that a non-significant amount of variance in the data 
remains unexplained. However, a statistically significant χ2 can often be produced as an artifact 
of sample size and of small variations in the data (33). The second criterion is the ratio of χ2 to 
the degree of freedom, a ratio ranging from 2 to 5 has been recommended as acceptable for 
good model fit (34, 35). The last criterion used is the root mean square error of approximation 
(RMSEA), which assesses how well the model approximates the data by determining the lack of 
fit of the model to the population covariance matrix, expressed as the discrepancy per degree of 








values up to 0.08 are acceptable as well (36). However, values greater than 0.10 strongly suggest 
an unsatisfactory model fit (37).
RESULTS
Data from 155 patients with COPD from GOLD stage I (n = 32), II (n = 65), III (n = 38) and IV 
(n = 20) were used for all analyses. The median (IQR) DPA level for the total group was 4206 
(2387–6284) steps/day (Table 1). Baseline scores of the questionnaires are shown in Table 2.
Table 1. Baseline characteristics (n = 155).
Clinical characteristics
Age, years 62 (54–69)
Gender, m/f 102/53
Healthcare setting, GP/outpatient cl./PR (n) 48/46/61
Medication (n)
 Short acting beta agonist 43
 Short acting muscarinic antagonist 35
 Long acting beta agonist 21
 Long acting muscarinic antagonist 83
 ICS 32
 Combination (ICS + long acting beta agonist) 99
Packyears 33 (17–50)
BMI, kg/m2 26.1 (22.8–29.0)
FFMI, kg/m2 17.4 (16.1–18.9)
FEV1, % pred 60 (40–75)
FEV1%FVC, % 45 (34–59)
RV%TLC, % 47 (41–54)
6MWD, m 452 (360–515)
DPA, steps/day 4206 (2387–6284)
Values are presented as median (IQR) unless otherwise indicated.
GP: general practice; PR: pulmonary rehabilitation; ICS: inhaled corticosteroids; FEV1: Forced Expiration 
Volume in one second; BMI: body mass index; 6MWD: six-minute walking distance; DPA: daily physical 
activity.
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Table 2. Baseline questionnaire scores.
GARS total score 23 (18–33)
SF-36 physical functioning 21 (16–26)
SF-36 social functioning 8 (7–10)
SF-36 physical role 6 (4–8)
SF-36 emotional role 6 (5–6)
SF-36 mental health 25 (21–27)
SF-36 vitality 16 (13–18)
SF-36 pain 50 (44–60)
SF-36 general health perception 13 (10–16)
SF-36 health change 4 (3–4)
CCQ symptoms 2.0 (1.3–2.8)
CCQ functional 1.3 (0.5–2.8)
CCQ mental 0.0 (0.0–0.5)
CCQ total 1.4 (0.8–2.2)
SGRQ symptoms 56 (36–70)
SGRQ activity 59 (30–79)
SGRQ impacts 26 (11–40)
SGRQ total 40 (22–54)
DEFS total score 3 (1–7)
PPAS total score 30 (24–35)
HADS anxiety 5 (3–8)
HADS depression 4 (2–6)
SRQ-E 10.1 (6.8–12.8)
Values are presented as median (IQR).
GARS: Groningen Activity Restriction Scale; SF-36: Short Form 36; CCQ: Clinical COPD Questionnaire; 
SGRQ: St. George Respiratory Questionnaire; DEFS: Dutch Exertion and Fatigue Scale; PPAS: Perceived 
Physical Ability Subscale of the physical self-efficacy scale (Dutch version); HADS: Hospital Anxiety and 
Depression Scale; SRQ-E: Self-Regulation Questionnaire for Exercise.
Correlations
Spearman’s correlations for all variables with DPA are shown in Table 3. Correlations of 
functional variables with psychological variables are shown in the Supplementary material. In 
general, patients with low functional status show weaker associations of DPA with psychological 
factors (anxiety, depression, self-efficacy; all rho’s ≤0.20 and non-significant) and stronger 
associations of DPA with variables reflecting functional capacity (except SGRQ impacts all 
rho’s >0.20, all p < 0.05) (Table 4). For patients with higher functional status associations of 
DPA with psychological variables are significant for self-efficacy and depression. In addition, 








significantly associated with DPA than in patients with low functional status (only 6MWD, SGRQ 
activity, CCQ function and DEFS).
 















FEV1: Forced Expiration Volume in one second; DPA: daily physical activity; 6MWD: six-minute walking 
distance; GARS: Groningen Activity Restriction Scale; SF-36: Short Form 36; SGRQ: St. George 
Respiratory Questionnaire; CCQ: Clinical COPD Questionnaire; DEFS: Dutch Exertion and Fatigue 
Scale; PPAS: Perceived Physical Ability Subscale of the physical self-efficacy scale (Dutch version); HADS: 
Hospital Anxiety and Depression Scale; SRQ-E: Self-Regulation Questionnaire for Exercise. a Correlation 
is significant at the 0.05 level (2-tailed).b Correlation is significant at the 0.01 level (2-tailed).
Regression analyses
In the stepwise multiple linear regression model 6MWD and SGRQ activity were predictors 
of DPA (Table 5). The model explains 37% of the variance, in which psychological variables did 
not contribute significantly. To further assess the contribution of psychological factors on DPA 
we performed a stepwise multiple linear regression containing only the psychological variables 
(Table 6). This model explains 16% of the variance with only PPAS (self-efficacy) as a significant 
independent predicting variable.
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Table 4. Correlations of DPA for low and high functional status separately.
Low functional status (6MWD <452) High functional status (6MWD ≥452)
DPA (steps/day) p DPA (steps/day) p
FEV1, l 0.312 0.009 0.137 0.247
6MWD, m 0.454 0.000 0.375 0.001
GARS total −0.344 0.004 −0.228 0.053
SF-36 physical function 0.287 0.017 0.151 0.199
SGRQ activity −0.288 0.016 −0.357 0.002
SGRQ impacts −0.091 0.481 −0.181 0.129
CCQ function −0.247 0.038 −0.251 0.032
DEFS −0.260 0.035 −0.296 0.011
PPAS 0.201 0.101 0.393 0.001
HADS anxiety −0.154 0.209 −0.219 0.061
HADS depression −0.033 0.791 −0.283 0.015
SRQ-E 0.091 0.459 0.075 0.530
p-values <0.05 printed bold.FEV1: Forced Expiration Volume in one second; DPA: daily physical activity; 
6MWD: six-minute walking distance; GARS: Groningen Activity Restriction Scale; SF-36: Short Form 
36; SGRQ: St. George Respiratory Questionnaire; CCQ: Clinical COPD Questionnaire; DEFS: Dutch 
Exertion and Fatigue Scale; PPAS: Perceived Physical Ability Subscale of the physical self-efficacy scale 
(Dutch version); HADS: Hospital Anxiety and Depression Scale; SRQ-E: Self-Regulation Questionnaire 
for Exercise.
 
Table 5. Resulting multiple regression model for explaining DPA from functional and psychological variables 
(method stepwise).
Unstandardized coefficients Standardized coefficients t Sig.
B Std. error
Constant 2703.165 1329.575 2.033 0.044
6MWD, m 7.899 2.053 0.378 3.848 0.000
SGRQ activity −0.016 9.706 −0.275 −2.801 0.006
R2 = 0.37, adjusted R2 = 0.36.
6MWD: six-minute walking distance; SGRQ: St. George Respiratory Questionnaire.
Table 6. Resulting multiple regression model for explaining DPA from psychological variables (method 
stepwise).
Unstandardized coefficients Standardized coefficients t Sig.
B Std. error
Constant 557.866 855.313 0.652 0.515
PPAS 143.131 24.604 0.400 5.185 0.000
R2 = 0.16, adjusted R2 = 0.15.









Based on the results of the regression analyses we hypothesized that psychological variables 
might indirectly affect DPA by affecting variables reflecting functional capacity. Path coefficients 
(standardized regression coefficients) are shown in Fig. 1 indicating a possible causal linkage 
between the latent variables psychological capacity and functional capacity (0.45) and between 
the latent variable functional capacity and steps/day (0.62). Analysis of the model fit shows 
a χ2 = 161.8, (df = 63); p < 0.001 and RMSEA = 0.10. The model shows a clear, but indirect, 
association between psychological variables and DPA. A model with a direct association of 
psychological capacity with DPA was tested as well, but this association was very low and not 
significant. The fit of the model meets the criteria of the relative normed χ2 (χ2/df) of Wheaton 
et al. and the criteria of the RSMEA (34) and (35).
Figure 1. The path diagram shows the causal relationship (bold arrows) between the latent variables 
psychological capacity, functional capacity and DPA. The strength of this relationship is shown by the 
path coefficient (standardized regression coefficient). The relationship of the observed variables with 
the latent variables is specified by the correlation coefficient.
DISCUSSION
DPA level in our COPD population was low, with a median (IQR) of 4206 (2387–6284) steps per 
day, which is considered to be sedentary (38). In the univariate analysis, DPA was significantly 
associated with variables reflecting functional capacity (performance-based and self-reported), 
and with psychological variables (depression and self-efficacy). When subjects were divided in 
having lower or higher functional status, DPA in patients with a lower functional status showed 
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significant associations with seven of the variables reflecting functional capacity (i.e. FEV1, 
6MWD, GARS total, SF-36 physical function, SGRQ activity, CCQ function and DEFS), whereas 
DPA in patients with a higher functional status showed significant associations with only four 
of these variables (i.e. 6MWD, SGRQ activity, CCQ function and DEFS). In addition, DPA in 
patients with a higher functional status was significantly associated with two psychological 
variables (i.e. self-efficacy and depression), which was not found in patients with low functional 
status.
Multivariate analysis showed only two significant variables, both reflecting functional capacity 
(6MWD and SGRQ activity) explaining 37% of the variance of DPA. However, the structural 
equations model (SEM) suggests that psychological variables indeed do contribute to DPA, but 
indirectly, through an effect on variables reflecting functional capacity.
Functional capacity and daily physical activity
The observed associations of DPA with variables reflecting functional capacity in the regression 
analyses and structural equations model are in line with other studies in COPD showing a 
relationship of higher DPA with higher FEV1(1-3, 7, 8, 14) higher general quality of life (SF-36) 
(3,6), and higher disease specific quality of life (SGRQ and CCQ) (4, 8, 14). The 6MWD, which 
explained the largest part of the variance in our multiple regression model, was also found to 
be a determining factor in three other studies (1, 3, 4). We hypothesize that the relationship 
between functional capacity and DPA is reciprocal: better functional capacity indeed enables a 
higher DPA level, but on the other hand a higher DPA level will lead to better functional capacity.
The relationship of DPA with variables reflecting functional capacity has also been demonstrated 
in other populations. For example, a moderate positive association of DPA with peak exercise 
VO2 has been shown in healthy subjects (18), and in patients with diabetes mellitus (39). In 
patients with heart failure a higher 6MWD was associated with higher DPA level (40). In our 
study, DPA was negatively associated with disability (GARS), which has to our knowledge not 
been reported before. In addition, fatigue (DEFS) was negatively associated with DPA, which 
has been found as well in one other study in COPD (41). Fatigue is particularly interesting as it 
is increasingly recognized as an important outcome in COPD (42) and other populations, such 
as frail elderly (43). Fatigue may negatively affect DPA level, which leads to deconditioning and 
consequently contributes to the vicious circle of dyspnea and fatigue.
Psychological capacity and daily physical activity
The relationship of DPA with psychological factors in COPD is less clear than the relationship 
with variables reflecting functional capacity. In our study, having higher self-efficacy and less 








symptoms were not independent determinants of DPA in a multiple regression model which also 
included variables reflecting functional capacity. Nevertheless, in a model that included only 
psychological variables, self-efficacy explained a considerable part of the total variance (16%). 
This relationship of higher DPA with higher self-efficacy has been shown as well in two other 
studies in COPD (3, 14) . Depressive symptoms, however, were not related to DPA in two earlier 
studies (2,6). This difference in findings might be caused by the use of a different questionnaire 
(Beck Depression Index) (2) or lack of power in the second, small study (6).
In other populations than COPD there is some evidence for a relationship of DPA with 
psychological variables. For instance, in healthy elderly (44, 45) and in subjects at risk for 
diabetes (46) higher scores on self-efficacy were related to higher DPA levels. In addition, in 
subjects at risk for diabetes having less symptoms of anxiety and depression was also related 
to higher DPA levels (46).
Interaction of functional and psychological capacity
Psychological variables affected DPA indirectly by influencing functional variables in our study, 
which is supported by several other studies in COPD. Cross-sectionally it has been shown 
in one study that a higher score on depressive symptoms is predictive for a lower walking 
distance (6MWD) (47). In addition, two longitudinal studies aiming at treatment of symptoms 
of depression and anxiety gave insight into the relationship between psychological factors and 
6MWD. The first study demonstrated that cognitive behavioral therapy and education both 
improved levels of depression and anxiety and performance in 6MWD (48). The second study 
compared pulmonary rehabilitation combined with psychotherapy to pulmonary rehabilitation 
alone. Both treatment arms improved walking distance, but it appeared that only pulmonary 
rehabilitation + psychotherapy improved scores of anxiety and depression (49). In summary, the 
results suggest at least a close, but not clearly understood, relationship between psychological 
variables and variables reflecting functional capacity, which might be reciprocal.
A strong point in our study is the use of structural equations modeling (SEM), which provides 
a more extensive insight in the complex relationship of DPA with functional and psychological 
variables. In addition, the broad group of studied COPD patients warrants better validity than 
studies with more specific groups of patients did (3, 8). Although the number of participants 
per subgroup (healthcare setting) seems limited we belief we selected sufficient patients from 
three different healthcare settings. We think that our results are therefore valid for patients 
as they are present in usual care.
Moreover, our extensive set of instruments covered more aspects of related factors than earlier 
studies. There are some limitations. The patient group in this study was rather small to perform a 
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path analysis, which might have caused the moderate fit of the model (33). However, the values in 
the model are well interpretable and no negative error variance or associations >1 were shown, 
which indicates a fair causal model.
Another limitation is that DPA was measured with a pedometer, which is less accurate than 
an accelerometer. The Yamax Digiwalker 200, however, has shown to be the most accurate 
pedometer at moderate to slow gate speed and only tended to underestimate the number 
of steps at very low gate speed (50). Furthermore, pedometers are more accurate than 
questionnaires and diaries, less expensive and time consuming than double labeled water or 
direct observation, and easy to use, and therefore allow inclusion of a large cohort (51).
In conclusion, DPA levels in COPD are low. A better functional capacity is strongly and 
independently associated with higher levels of DPA. Psychological factors such as anxiety, 
depression and self-efficacy also affect DPA, but indirectly by an effect on functional capacity. 
Finally, the influence of psychological factors seems larger in patients with better functional 
capacity. There is a need for investigating whether treatment of psychological factors should be 
addressed when patients enroll in an exercise training or physical activity counseling program 
and whether the effects depend on functional capacity.
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ABSTRACT
Objective: To investigate whether a 12-week pedometer-based exercise counseling strategy 
is feasible and effectively enhances daily physical activity in outclinic COPD patients who do 
not participate in rehabilitation program in a controlled way.
Methods: 35 outclinic COPD patients (21 males, mean age 62 yrs, GOLD I-III, mean FEV
1
% 
predicted 64.7) were randomized for a 12-week individual pedometer-based exercise counseling 
program promoting daily physical activities or usual care. Daily physical activity (DigiWalker 
SW-200), physical fitness, health-related quality of life, self-efficacy, fatigue, depression and 
motivation to be physically active were assessed before and after the intervention.
Results: After the intervention, COPD patients in the exercise counseling group showed a 
significant increase in their mean number of steps/day (from 7087 to 7872), whereas the usual 
care group showed a decrease (from 7539 to 6172). Significant differences favoring the exercise 
counseling group were demonstrated in arm strength, leg strength, health-related quality of life 
and intrinsic motivation to be physically active.
Conclusion: Our study shows that a 12-week pedometer-based exercise counseling strategy is 
feasible and effectively enhances daily physical activity, physical fitness, health-related quality of 
life and intrinsic motivation in outclinic COPD patients who do not participate in a rehabilitation 
program.
Practice implications: The feasibility of our exercise counseling strategy is good and patients 
were motivated to participate.
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INTRODUCTION
Chronic Obstructive Pulmonary Disease (COPD) is characterized by cough, phlegm, dyspnea, 
decreased exercise tolerance and exacerbations. COPD patients may enter a downward spiral 
of symptom-induced inactivity leading to lack of fitness and a reduced quality of life. It has been 
demonstrated that during one day, COPD patients spend more time sitting and lying down and 
less standing and walking than age-matched healthy controls (1). To reverse this vicious circle of 
inactivity it is important to prevent the decrease in daily physical activity or even to enhance it.
Enhancement of low-to-moderate-intensity daily physical activity has proven to be effective 
in strengthening health-related fitness and quality of life in healthy older adults (2-3). Because 
COPD patients frequently suffer from ventilatory limitations and oxygen uptake problems, low-
to-moderate-intensity physical activities seem an appropriate level to enhance their physical 
fitness (4). To monitor enhancement of daily physical activity pedometers have shown to be 
effective in healthy people as well as in various patients groups (5-8). Pedometers are also 
key in triggering enhancement of daily physical activity (9-12). In addition, exercise counseling 
has shown to be effective in tailoring the needs and circumstances of individual patients in the 
process of behavioral modification (13-14).
In this study, we investigated whether a 12-week pedometer-based exercise counseling 
strategy is feasible and effectively enhances daily physical activity in COPD patients who do 
not participate in a rehabilitation program.
METHODS
Participants and recruitment
Patients with stable COPD visiting the outpatient clinic of the pulmonary department of 
Wilhelmina Hospital in Assen were approached to participate in this study. Inclusion criteria 
were diagnosis of COPD and age between 45 and 75 years. Exclusion criterion was significant 
comorbidity interfering with physical activity. The study was approved by the local medical 










All measurements were taken at baseline and following the intervention period.
- Daily physical activity was measured with a pedometer (Digiwalker SW-2000 (Yamax; 
Tokyo, Japan)) (10).
- Pulmonary function was measured using a spirometer (Jaeger MS-IOS) according to 
standardized guidelines (15).
- Physical fitness: Leg strength was measured by the chair-stand-test (16-17), arm strength 
by the arm-curl-test (16-17), grip force by a handheld dynamometer and cardiorespiratory 
endurance by the 6-minute walking test (18).
- Health-related quality of life was measured by the Clinical COPD Questionnaire and the St. 
George Respiratory Questionnaire (19-20). Health status was measured by the SF-36 (21).
- Fatigue was measured by the Dutch Exertion Fatigue Scale (22).
- Depression was measured by the Beck Depression Inventory (23).
- Self-efficacy was measured by the LIVAS (24-25).
- Motivation to be physically active was measured by the Exercise Self-Regulation 
Questionnaire.
Intervention
Patients were randomly assigned to an exercise counseling or a usual care group. The exercise 
counseling group participated in a 12-week customized exercise counseling program designed 
to enhance daily physical activity in COPD patients (26). Patients started the program in the 
late summer and finished it in the early winter. The exercise counseling program was given by 
a trained exercise counselor (the first author) and is predominantly based on the principles 
of goal setting and implementation of goals (27). Motivational interviewing technique (28) is 
used as counseling technique. A pedometer, worn all day during the intervention period, was 
used to monitor and support motivation to participate. Aim of the exercise counseling was to 
motivate COPD patients to enhance daily physical activities and to develop a more physically 
active lifestyle. Five individually tailored exercise counseling sessions took place during 12 weeks 
(table 1). Each session lasted approximately 30 minutes.
Patients in the usual care group received usual care and wore the pedometer for two weeks at 
baseline and 10 weeks after baseline.
Statistical analysis
All statistical analyses were performed using Scientific Package of Social Sciences (SPSS) 
version 14.0. The Mann-Whitney U-test and the Chi-square test were used to analyze 
baseline characteristics. A factorial ANOVA (group x time) was used to examine the effect of 
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the intervention. Effect sizes were computed (32) and a power analysis was calculated (33). To 
test the null hypothesis alpha was set at .05 and beta at .80.
Table 1. Exercise counseling sessions
Visit Week Topic of the counseling session Behavioral theory
1 0 Motivation for increasing physical activity level 
by focusing on motives to change behavior and 
assessing the baseline status of physical activity
The Self-Determination Theory [29] 
The Stage of Change Theory [30]
2 3 Setting individual goals: SMART (specific, 
measurable, acceptable, realistic en timed) 
criteria and implementation protocols are used 
by the exercise counselor
The Goal-setting Theory [29]
The Relapse Prevention Model [31]
3 6 Seeking personal physical activity limits by 
shifting boundaries
The Goal-setting Theory [29]
4 9 Consolidation of physical activity behavior; set 
a personal goal
The Goal-setting Theory [29]
5 12 Evaluation
The exercise counselor gives information about 
self regulation principles to cope with laps and 
relapse
The Relapse Prevention Model [31]
RESULTS
The flow of participants through the study is shown in figure 1. Descriptive characteristics at 
baseline are shown in table 2.
Table 2. Descriptive characteristics at baseline.
Exercise counseling Usual care p-value
Number 18 17
Gender, M/F 10/8 11/ 6 .24
Age, years 63.1 (8.3) 61.2 (9.1) .41
BMI, kg/m2 27.8 (6.8) 26.6 (3.5) .80
FEV
1
, L 1.9 (0.7) 1.8 (0.5) .90
FEV
1
, % predicted 67.4 (17.5) 61.8 (14.4) .42
TLC, % predicted 112.0 (19.8) 114.3 (13.6) .87
RV, % predicted 136.6 (30.5) 146.0 (29.3) .40
ITGV, % predicted 128.8 (30.8) 131.3 (27.0) .96
GOLD
Stage I 4 (22) 1 (6)
Stage II 11 (61) 12 (71) .35
Stage III 3 (17) 4 (23)


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The exercise counseling group increased its mean number of steps/day by 11% (table 3). By 
contrast, the usual care group showed a decrease in their mean steps/day of 18%. In the exercise 
counseling group about 56% of the participants showed an increase, while in the usual care 
group 29% showed an increase in mean number of steps/day. This difference was significant.
Figure 1. Flow chart of the study.
Secondary outcome measure
The exercise counseling group, as compared to the usual care group, showed a beneficial 
significant effect on leg strength and arm strength (table 3). Moreover, a significant improvement 
was found on Quality of Life and changes in intrinsic motivation score. No significant differences 
were found for fatigue, health status, depression and self-efficacy. Controlled for number of 
steps/day at baseline, the results of a factorial ANOVA showed a significant increase in only leg 




Our study shows that a 12-week pedometer-based exercise counseling strategy is feasible 
and effectively enhances daily physical activity, physical fitness, health-related quality of life 
and intrinsic motivation in COPD patients who do not participate in a rehabilitation program.
COPD patients in the exercise counseling group increased their number of steps by 11%. COPD 
patients who took less than 10.000 steps/day at baseline increased their number of steps by 
about 19%. This corresponds with about 20 minutes walking per day. Still, a mean number of 
6124 steps post-program is far below the arbitrary cut-off point of 10.000 steps/day for healthy 
adults. For physically active COPD patients (>10.000 steps/day at baseline) who participated in 
the exercise counseling group the number of steps did consolidate. Contrary, physically active 
participants in the usual care group demonstrated a dramatic fall in number of steps/day by 21%. 
One might suggest that this dramatic fall is due to a seasonal effect (34-35). Patients started the 
program in the late summer and finished it in the early winter. It is conceivable that physically 
active COPD patients reduce their outside physical activities in the early winter because of 
bad weather.
The increase in daily physical activity level of COPD patients in the exercise counseling group is 
supported by a systematic review study of Bravata and colleagues (14), who show pedometer 
users significantly increased their physical activity by 2491 more steps/day than control 
participants (95% confidence interval 1098-3885 steps/day, P=.001). In our study the difference 
between the exercise counseling and usual care group is 2152 steps/day.
Sedentary COPD patients in the exercise counseling group show significant improvement of leg 
strength and arm strength. Apparently, enhancing daily activities provides an adequate training 
stimulus, at least in COPD patients with a decreased active lifestyle. The 6-minute walking test 
improved by 26m in the exercise counseling group, compared to 10m in the usual care group. 
Both changes are below the minimal clinically relevant change. Nevertheless, we hypothesize 
that for the exercise counseling group the 6-minute walking test will further improve if patients 
stick to their new lifestyle.
The question arises whether pedometer-based counseling programs should be used as an 
alternative to regular pulmonary rehabilitation programs, especially for COPD patients who 
cannot benefit from regular pulmonary rehabilitation due to budgetary restrictions. In our 
opinion, the benefits of an exercise counseling strategy are evident: it is our experience, also in 








and different caregivers can be trained to give exercise counseling. Nevertheless, we realize 
that specific COPD patients, like those severely deconditioned, really need the multidisciplinary 
approach of a pulmonary rehabilitation program. We previously published a study in which we 
enhanced daily physical activity in COPD patients in pulmonary rehabilitation, using the same 
exercise counseling strategy. We showed that our exercise counseling strategy was feasible 
next to pulmonary rehabilitation (26). In our opinion, pulmonary rehabilitation and exercise 
counseling may act complementarily and synergistically.
Conclusion
Our study shows that a 12-week pedometer-based exercise counseling strategy is feasible and 
effectively enhances daily physical activity, physical fitness, health-related quality of life and 
intrinsic motivation in outclinic COPD patients.
Practice Implications
Pedometers are simple in use, and the feasibility of the counseling program is good. Patients 
were motivated to participate in this study, and the dropout rate is low. The strengths of the 
study are the feasibility and effectiveness of the exercise counseling strategy in sedentary 
COPD patients. Especially the significant increase in daily physical activity and leg strength 
are amenities of this study. Limitation of the study is the lack of long-term follow-up.
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ABSTRACT
Background: Information about daily physical activity of COPD lung transplant patients 
is relevant in order to evaluate the functional recovery of physical capacity after lung 
transplantation. The objective of this study was to cross-sectionally assess daily physical activity, 
pulmonary function, physical fitness, fear of physical activity and motivation to exercise in COPD 
patients who were lung transplant candidates and lung transplant recipients.
Methods: Fifteen COPD lung transplant candidates (5 males, mean age 53 years, FEV
1
 20% 
predicted) and 47 recipients (18 males, mean age 55 years, FEV
1
 93% predicted, 39 bi-, 8 
unilateral transplanted) were enrolled in this observational study. Daily physical activity was 
measured using a pedometer (Digiwalker SW-200) and the Short Questionnaire to Assess 
Health-enhancing physical activity. Physical fitness was measured by the sit-to-stand test and 
the arm curl test. Fear of physical activity and motivation to exercise was measured by the 
Tampa Scale for Kinesiophobia Dutch Version questionnaire and the Exercise Self-Regulation 
Questionnaire.
Results: Mean (±SD) number of steps/day in lung transplant recipients was higher compared 
to candidates: 6642 (±2886) versus 1407 (±1166 (p<.05)). Number of steps/day correlated 
significantly with FEV
1
 (r=0.32, p=0.03) and lower-body strength (r=0.45, p=0.002) in lung 
transplant recipients. There was no significant difference in daily physical activity, physical 
fitness, fear and motivation between bi- and unilateral transplant recipients.
Conclusion: Our data suggest that lung transplantation improves daily physical activity, lower-





Lung transplantation is a seriously considered treatment option for patients with end-stage 
chronic obstructive pulmonary disease (COPD) for whom no alternative modality is available 
anymore (1;2). To assess effectiveness of lung transplantation, survival, pulmonary function, 
physical fitness and health-related quality of life before and after lung transplantation are 
frequently compared (3).
Daily physical activity might be another interesting outcome variable of lung transplantation 
that is relevant for the perception of patient’s quality of life. Daily physical activity level can 
be defined as the actual level of performance one adopts in daily living. This is related to, 
but different from, functional capacity, usually determined by biological physical fitness and 
limited by disease-related impairments. To maintain fitness in adults, the American College of 
Sports Medicine (ACSM) states that a minimum of 30 minutes of physical activity of moderate 
intensity, is necessary on top of instrumental activity of daily living (4). Recommendations for 
healthy adults are to walk 10.000 steps per day. Schönhofer and colleagues showed that the 
mean level of daily physical activity, measured in steps/day, is 3 times higher in healthy subjects 
compared to moderate to severe COPD patients (5). In addition, Pitta and colleagues showed 
that patients with mild to severe COPD spend significantly less time walking and standing and 
more time sitting and lying in daily life compared with sedentary healthy subjects (6). Compared 
to lung tranplant candidates, recipients have shown significant improvements on the physical 
functioning scale of health related quality of life questionnaires (7-9). For patients with COPD 
a bilateral lung transplantation is associated with superior lung function, exercise tolerance, 
increased physical ability ratings and a trend toward enhanced survival (1;10). Consequently, the 
question rises if single-lung transplant recipients show decreased levels of daily physical activity.
Up to now, there is scarce information about the level of physical activity and its contributing 
factors in COPD lung transplant patients. Despite significant improvement in pulmonary 
function after lung transplantation, physical fitness remains diminished due to peripheral muscle 
limitations (2;11;12). Peripheral muscle force may be limited due to post-transplantation factors 
such as immunosuppression, which in addition to preventing rejection might influence both 
skeletal muscles and the cardiovascular system, thereby changing physical activity patterns (13).
The aim of this cross-sectional study was to examine the daily physical activity status of COPD 
lung transplant patients in relation to pulmonary function, physical fitness, fear of physical 
activity and motivation to exercise. A pedometer was used in this explorative study to obtain a 










Hundred-twenty-six COPD patients received a lung transplant at the University Medical 
Centre Groningen between 1990 and 2005. Sixty-six of them were still alive, together with 
16 candidates for transplantation. These patients were considered for inclusion in this cross-
sectional study. Inclusion criteria were: lung transplant patients diagnosed with COPD or 
emphysema caused by an α
1
-antitrypsin deficiency. Exclusion criteria were: not visiting the 
outpatient clinic in the research period (recipients, n=2; candidates, n=1), re-transplanted 
(n=2), not able to wear a pedometer because they were laid up with complications (n=2). Of 
all eligible patients, 6 were lost to follow up and 7 refused to participate. Forty-seven lung 
transplant recipients and fifteen lung transplant candidates were included. The study protocol 
was approved by the local ethics committee of the hospital and all patients signed a consent 
form. Patient characteristics are shown in table 1.





Gender (male/female) 5/10 18/29
Age (years) 53 ± 6.3 55 ± 5.5
Age at transplantation (years) 50 ± 5.7
Months after listing (Months) 13 ± 13
Months after LTx (Months) 66 ± 48
Transplantation (bi/uni) 39/8







FFMi (kg/ m2) 15 ± 1.7 17 ± 2.9
FEV
1
 (% pred) 20 ± 5.2 93 ± 28.4
FEV
1
 percentage of baseline (%) 87 ± 13.5
 BOS grade 1 (%) 13%
 BOS grade 2 (%) 4%
 BOS grade 3 (%) 2%
Use of Oxygen 11 0
Values are means ± standard deviations. bi, bilateral transplanted; uni, unilateral transplanted; BMI, Body 
Mass Index; FFMi, Fat-Free Mass Index; FEV
1
, Forced Expiratory Volume in 1 second; FEV
1
 percentage 
of baseline, percentage of best postoperative value of FEV
1
; BOS grade 1: FEV
1 
66% to 80% of baseline; 
BOS grade 2: FEV
1 
51% to 65% of baseline; BOS grade 3: FEV1 50% or less of baseline.
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Six of the fifteen lung transplant candidates received prednisolone (maintenance dose varying 
from 5-25mg, during 12-60 months). All lung transplant recipients received postoperative 
immunosuppression induction consisting of rabbit anti-thymocyte globulins (Thymoglobulin) 
or anti-CD25 monoclonal antibodies (Simulect) during the first postoperative week, and 
maintenance triple immunosuppression with cyclosporine (Neoral) (target trough levels of 
150µg/L) or tacrolimus (Prograf) (target trough levels of 10-12µg/L) plus azathioprine (Imuran) 
(2mg/kg body weight) or mycophenolate mofetil (Cellcept) (1000mg bid) plus prednisolone 
(maintenance dose of 0.1mg/kg).
All subjects underwent a regular rehabilitation program. Before lung transplantation the 
rehabilitation program focused on muscle reinforcement and preservation of endurance. The 
first 2 years after lung transplantation the rehabilitation program focused on muscle strength 
in relation to the functional capabilities of the patient.
Methods
Pulmonary function characteristics
Pulmonary function was measured using a spirometer (Jaeger MS-IOS) according to 
standardized guidelines (14). Reference values used were those of the European Community 
for Coal and Steel (14).
The severity of bronchiolitis obliterans syndrome (BOS) was graded by the recommendations 
of the International Society for Heart and Lung Transplantation (15).
Performance based daily physical activity
Daily physical activity was assessed by the Digiwalker SW-200 (Yamax; Tokyo, Japan) (16-18). 
This pedometer has proved to accurately detect steps taken, as an indication of volume of daily 
physical activity. It has shown evidence of reliability and convergent and discriminative validity 
(18). In controlled laboratory settings, the Yamax SW series pedometers have consistently been 
shown to be among the most accurate. The SW-701 (which has the same step count mechanism 
as the SW-200) consistently gave values within 3% of actual steps taken during a self-paced 
walk, on an individual basis (intramodel reliability: Cronbach’s α=0.99) (16;17;19). In this study 
patients were strongly encouraged not to make any changes to their typical daily routine of 
work and leisure activity. Patients were instructed to wear the pedometer during ten days, 
to record the number of steps and the number of minutes that they were cycling, swimming 
or doing fitness per day. Non-ambulatory activities were converted into steps based on the 
intensity of this physical activity calculated in Metabolic Equivalents in minutes (MET/min), for 
example: 1 minute cycling or swimming is about 150 steps, 1 minute fitness about 100 steps. 








out of ten daily-records were used for processing, in order to exclude a novelty effect and to 
include every day of the week.
Self-reported based daily physical activity
Daily physical activity was assessed in self-reported fashion with the Short QUestionnaire to 
ASsess Health-enhancing physical activity (SQUASH) (20). The SQUASH is designed to assess 
the habitual activity level, and has shown to be a moderately reliable and valid questionnaire; 
the Spearman correlation for overall reproducibility of the SQUASH is 0.58 (95%-CI 0.36-
0.74). Correlations for the reproducibility of the separate questions vary between 0.44 and 
0.96. Spearman’s correlation coefficient between Computer Science and Applications Activity 
Monitor readings and the total activity score was 0.45 (95%-CI 0.17-0.66) (20). Activities are 
expressed in MET/min and total minutes a week.
Physical fitness
A Bioelectrical Impedance Analysis (Bodystat 1500) was used to measure fat-free mass (21).
The sit-to-stand test was used to assess lower-body strength (22;23). This test involves counting 
the number of times, within 30 seconds, that the patient can come to a full stand from a seated 
position without using his arms. The sit-to-stand test has been shown to be reliable (test-retest 
correlation r=0.80) and has been validated against the gold standard measure for lower-body 
strength, the leg-press test (criterion validity related to leg press is r=0.77 (test-retest)) (22;23). 
The stand-to-sit test was strongly correlated with the 6 minute walking test in patients with 
COPD (r=0.75, p<0.001) (24).
The arm curl test was used to assess upper-body strength. The patient performed as many 
biceps curls as possible in 30 seconds (22;23). Female participants performed the arm curl test 
using a 2-kg dumbbell; the men used a 3-kg dumbbell. Reliability (test-retest) is r=0.81 (22;23).
Fear of physical activity
Fear of exercise was measured using the Tampa Scale for Kinesiophobia Dutch Version 
questionnaire (TSK-DV) (25;26). The TSK-DV consists of four components: harm, fear of injury, 
avoidance of activity and importance of exercise. The higher the score on a component, the 
greater the role of that component is in fear of exercise. The TSK-DV has shown to have a good 
reliability and a respectable internal consistency (α=0.68 to α=0.80) (25-27).
Motivation to exercise
The level of the motivation to exercise was measured using the Exercise Self-Regulation 
Questionnaire (SRQ-E). The basic issue concerns the degree to which one feels autonomous 
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(i.e. “in control”) with respect to engaging in physical activities (28). The responses represent 
external regulation, introjected regulation, identified regulation and intrinsic motivation.
Statistical analysis
The statistical program SPSS (version 14.0) was used for statistical analysis. Assumption of 
normality was tested using the Shapiro-Wilk test. Means and standard deviations (SD) were 
calculated for almost all outcome measures. Mann-Whitney tests were used to compare lung 
transplant recipients and candidates and to compare bi- and unilateral lung transplant recipients. 
Within the group of lung transplant recipients, correlation between different variables was 
analyzed using bivariate correlation analysis (Pearson’s and Spearman’s rank order). A 
discriminant analysis (method Enter) was done to analyze the relevant determinants of the 
physical activity status of lung transplant recipients. Discriminant analysis is preferred when 
the assumptions of linear regression are met since discriminant analysis has more statistical 
power than logistic regression.
RESULTS
Differences between lung transplant candidates and recipients
Table 2 shows the outcome characteristics of daily physical activity, muscle function and fear 
of physical activity and motivation to exercise. Daily physical activity (steps/day and step 
equivalents) was significantly lower in lung transplant candidates compared to lung transplant 
recipients. Between bi- and unilateral transplant recipients, there was no significant difference 
in daily physical activity (mean steps/day respectively 6667 and 6539, p=0.91), physical fitness 
(mean repetitions stand-to-sit test respectively 10 and 10.5, p=0.73) and fear (mean TSK-DV 
respectively 30 and 27, p=0.37) and motivation (mean Relative Autonomy Index respectively 53 
and 45, p=0.09). Figure 1 shows daily physical activity in percentages of active patients (figure 
1A) and in minutes/week (figure 1B) assessed with the SQUASH questionnaire. Compared 
to lung transplant candidates, lung transplant recipients were more physically active in daily 
life, showed to have better lung function, higher lower-body strength and less fear of physical 









Table 2 Outcome measures of lung transplant (LTx) candidates and recipients
LTx candidates n=15 LTx recipients n=47
Daily physical activity
 Steps (steps/day) 1407 ± 1166 6642 ± 2886*
 Step equivalents 2636 ± 2275 9038 ± 4583*
 SQUASH (MET/min) 1349 ± 990 5434 ± 2945*
Physical fitness
 Arm curl (reps) 14 ± 5.5 16 ± 4.5
 Sit-to-stand (reps) 7 ± 2.5 10 ± 4.4*
Fear and motivation
 TSK-DV 42 ± 6.0 30 ± 7.7*
 SRQ-E 47 ± 14.2 51 ± 11.9
Values are means ± standard deviations. Range in daily physical activity: 931-13747 steps/day, 931-22862 
step equivalents. *p<0.001 versus lung transplant candidates (Mann-Whitney test). SQUASH, Short 
QUestionnaire to ASsess Health-enhancing physical activity; TSK-DV, Tampa Scale for Kinesiophobia 
Dutch Version; SRQ-E, Exercise Self-Regulation Questionnaire.
Figure 1. (A) Percentage of patients who are active in one or more lifestyle physical activities assessed 
with the SQUASH Questionnaire. Values are expressed as percentages (physical therapy: pulmonary or 
regular rehabilitation; odd jobs: casual or isolated piece of work especially one of a routine domestic or 
manual nature).
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Figure 1. (B) Time spent on lifestyle physical activities assessed with the SQUASH Questionnaire. Values 
are means ± standard deviations among patients who were active in one of the categories as shown in (A).
In the categories ‘cycling’ and ‘sports 6.5 MET’ only one person was active (min/week); mean ± standard 
deviation could not be calculated (physical therapy: pulmonary or regular rehabilitation; odd jobs: casual 
or isolated piece of work especially one of a routine domestic or manual nature).
Factors contributing to daily physical activity in lung transplant recipients
There was a moderate correlation between daily physical activity (steps/day and steps 
equivalents) and FEV
1
 (%pred) (r=0.32; p=0.03; r=0.33; p=0.03), lower-body strength (r=0.45; 
p=0.002; r=0.34, p=0.02), and the number of months after transplantation (r=0.49; p=0.001; 
r=0.47; p=0.001) (Figure 2). However, it should be taken into account that only the living 
patients and patients who were fit enough to be physically active after lung transplantation 
were taken into account. There were no significant relations found in addition to upper-body 








Figure 2. Daily physical activity level of 47 COPD patients after lung transplantation measured with a 
pedometer. X-axis: number of months after lung transplantation. Y-axis: number of steps/day (upper panel), 
or number of step equivalents (lower panel). There is a strong increase in steps/day and step equivalents 
in the first 2 years after transplantation. It should be noted that no data are available of the subjects who 
have died after lung transplantation.
A discriminant analysis was done in order to assess which determinants affected the mean 
number of steps that lung transplant recipients took during one week. To this end, the lung 
transplant recipients were divided into two groups on the basis of their step count (‘high step 
count’ and ‘low step count’). The following variables were included: months after transplantation, 
type of transplantation (bi- or unilateral transplanted), FEV
1 
(%pred), lower-body strength, fear 
of movement and motivation. The results of the discriminant analysis showed that, based on 
the standardized discriminant functions, a high lower-body strength (0.73), a high FEV
1
 (%pred) 
(0.44), the number of months after transplantation (0.41), and a high motivation (0.24) affected 
the difference in physical activity of lung transplant recipients the most. Fear of movement (0.12) 
and type of transplantation (-0.10) seem to have less effect on the difference in physical activity 
of lung transplant patients. The canonic correlation was 0.63 (Wilk’s Lambda=0.60, df=6, 
p=0.002). Wilk’s Lambda shows the proportion of the total variance (63%) in the discriminant 
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scores not explained by differences among groups. A small Lambda value (near 0) indicates that 
the group’s mean discriminant scores differ. The p value (p<.002) is for the Chi-square test which 
indicates that there is a highly significant difference between the groups’ centroids. Seventy-
eight percent of the originally grouped subjects were correctly classified.
DISCUSSION
This study showed that daily physical activity was significantly higher in lung transplant 
recipients compared with lung transplant candidates. Lower-body strength, pulmonary function 
and number of months after transplantation contributed significantly to a higher daily physical 
activity level of lung transplant recipients. No significant relation between daily physical activity 
and fear of physical activity and motivation to exercise was found.
This study shows lung transplant recipients took approximately 6600 steps/day after lung 
transplantation. In line with previous reports (29), daily physical activity was not related 
with type of transplantation, uni- vs bilateral. The number of steps/day of lung transplant 
recipients corresponded with the daily physical activity level of a healthy population (30) and 
was significantly above the number of steps/day Tudor-Locke and Myers (31) suggest older 
adults and those living with a chronic disease could take (3500-5500 steps/day). Compared 
with moderate to severe COPD patients (3700 steps/day) (5), daily physical activity in lung 
transplant candidates was significantly lower. The large variability in the number of steps/day 
of lung transplant patients is common and depends on many factors (32). The amount of time 
spent on a lifestyle activity and the percentage of subjects active in a lifestyle physical activity 
was significantly higher after transplantation than before lung transplantation.
Lower-body strength was the most important determinant in the difference in daily physical 
activity in lung transplant recipients. Although this study showed that lower-body strength was 
significantly higher after lung transplantation, no significant difference was found for upper-
body strength. We suggest that muscle force in the upper-limb muscles (biceps and triceps) 
decreases less than muscle force of the lower limb (quadriceps), because physical activities that 
involve lower limbs are avoided before lung transplantation (33-36). In line with previous studies 
(2;12;37;38), lower-body strength of lung transplant recipients is still diminished and does not 
reach the level of healthy adults (22;31). The use of immunosuppressants, deconditioning and 
malnutrition may cause the lower status in lower-body strength.
Airflow obstruction, as seen in the early postoperative phase and in the context of bronchiolitis 
obliterans syndrome was found to be an important determinant in the daily physical activity 








The number of months after transplantation was another important determinant in the 
difference in daily physical activity in lung transplant recipients. During the first two years after 
lung transplantation there was a strong increase in daily physical activity level. It is intriguing that 
the daily physical activity level of lung transplant recipients, in spite of their muscle dysfunction, 
is similar to that of healthy subjects. Apparently lung transplant recipients chose a relatively high 
active life style, maybe to develop or remain a high level of physical fitness. However, it should 
be realized that patients who died and patients who were not fit enough to be physically active 
were not included in this cross-sectional study.
In contrast with the absence of a significant relation between daily physical activity and 
fear of physical activity that was found in lung transplant patients in this study, a number of 
studies reported a significant relation between physical activity and anxiety in COPD patients 
(39-41). Our study demonstrated that fear of movement was significantly lower in lung 
transplant recipients compared to lung transplant candidates. This is in line with recent studies 
reporting that mental state and health-related quality of life improve considerably after lung 
transplantation (39-41). Research by Goetzmann and colleagues (42) on the psychological status 
of lung transplant recipients showed that anxiety scores in lung transplant recipients meet the 
criteria of a healthy adult population.
We found no significant difference in motivation in lung transplant recipients compared to lung 
transplant candidates. We assume that lung transplant patients are very motivated to be physically 
active.
There were a number of methodological characteristics in the present study which are 
relevant for the interpretation of the results. Due to the small sample size in lung transplant 
candidates the study may have been underpowered, which affects its external validity. The 
observational character of this study limits its internal validity. The questionnaires used have not 
yet been validated for lung transplant patients. Comorbidity and its relation with daily physical 
activity was not assessed. Finally, the pedometer is not sensitive to non-ambulatory activities. 
Nevertheless, walking is one of the most common forms of activity, and in our study, there was 
no difference between steps/day and step equivalents related to secondary outcome measures. 
Despite the limitations of a pedometer, the use of this device is a relatively simple way to monitor 
the performance-based physical activity status of lung transplant patients and recipients.
In summary, our data suggest that lung transplantation improves the daily physical activity level, 
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ABSTRACT
Background: Obesity-related diseases have been shown to affect post lung transplantation 
survival. An estimated 30% of lung transplant recipients develop overweight.
Objective: The aim of this study was to examine the possible determinants of large increases in 
weight after lung transplantation. The contribution of physical activity, food intake and resting 
energy expenditure was examined in lung transplant recipients.
Methods: In this cross-sectional study 21 overweight lung transplant recipients (11 men, mean 
age 57±7 years, BMI 30±3 kg/m2) and 21 normal weight lung transplant recipients (11 men, 
mean age 56±5 years; BMI 22±3 kg/m2) were matched on disease, gender, age, prescribed 
medication and time since lung transplantation. Physical activity was measured by a pedometer 
and a questionnaire; resting energy expenditure by the ventilated-hood technique, and daily 
food intake by a dietician. Additionally, fat-free mass, lower body strength and fatigue were 
measured.
Results: The overweight lung transplant recipients had a significant lower number of steps/
day (4686±3266 versus 7524±3448 steps/day, p=0.01) and lower fat-free mass (64±9 versus 
75±6%, p<0.05) compared to normal weight recipients. Obese subjects had a lower percentage 
of predicted resting energy expenditure level compared to normal weighted recipients (90±14 
versus 100±14 %predicted, p=0.04).
Conclusion: Our data suggest that overweight in lung transplant recipients is associated 
with lower fat-free mass, lower level of physical activity level and resting energy expenditure 
compared to normal weight recipients.
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INTRODUCTION
Lung transplantation is one of the treatment options in patients with end-stage lung disease 
(1-3). In living lung transplant recipients of the University Medical Center Groningen 30 percent 
are overweight (body mass index (BMI) >25 kg/m2). In line, Culver et al (2005) showed that 
a similar percentage (33%) of their lung transplant recipients were overweight or obese (4). 
Obesity-related diseases such as type II diabetes, hypertension and cardiovascular disorders 
affect post lung transplantation survival (5-9). Five years after lung transplantation almost 17% 
of the deaths are accounted for by malignancies and cardiovascular causes (10). The 90-day 
mortality after lung transplantation increases 5-fold when the BMI before lung transplantation 
exceeds 27 kg/m2 (2;6;9;11). In the healthy male population weight gain is related with reduction 
in pulmonary function (12).
The principal factors for developing overweight and obesity in the general population are 
limited physical activity, excessive food intake and low resting energy expenditure (13-16). Up 
to now, there is only scarce information about the contributing factors of the development of 
overweight in lung transplant recipients. Ongoing administration of immunosuppressive therapy 
is associated with steroid myopathy and reduced skeletal muscle function in lung transplant 
recipients, which can cause limited exercise capacity (1;17-21) and consequently on the long-
term also a reduced daily physical activity. Indeed, in the first year after lung transplantation a 
40% lower number of steps compared to healthy controls was observed (22). However, after 
2 years the number of steps per day was found to be comparable to that of healthy persons 
(21). Ongoing corticosteroid intake may also stimulate appetite and lead to increased BMI, as 
demonstrated in kidney and heart transplant recipients (23;24). A decreased resting energy 
expenditure may theoretically also contribute to increased BMI, as was shown in liver transplant 
recipients (25). This contrasts with findings in healthy obese women that showed that obesity 
was linked with high values of resting energy expenditure and the fact that resting energy 
expenditure increased with higher BMI (26). Obviously, we can only speculate about the 
specific underlying factors of overweight in lung transplant recipients. To prevent or to treat 
the development of overweight in a causal way, we believe it is very important to understand 
the underlying factors and their relationship.
The aim of this cross-sectional study was to examine the possible determinants of large increases 
in weight after lung transplantation. In this study the role of daily physical activity, resting energy 
expenditure and daily food intake was examined in lung transplant recipients with the most 











In this study 42 lung transplant recipients of the University Medical Center Groningen were 
included (table 1). Inclusion criteria for all participants were: age >18 years, lung transplantation 
more than one year ago, COPD or lung fibrosis being the underlying disease state, and having 
signed a written informed consent.
 
Table 1. Characteristics of the normal weight and overweight/obese lung transplant recipients.
Normal weight
lung transplant recipients 
(n=21)
Overweight/obese
lung transplant recipients  
(n=21)
Gender (M/F) 11 / 10 11 / 10
Age (years) 56 ± 5 57 ± 7
Underlying disease (COPD/lung fibrosis) 17 / 4 17 / 4
Lung transplantation (unilateral/bilateral) 5 / 16 5 / 16
Time since lung transplantation (months) 85 ± 49 73 ± 48
BMI before lung transplantation (kg/m2) 21 ± 3 24 ± 3
Actual BMI (kg/m2) 22 ± 3 30 ± 3 *
Actual weight (kg) 66 ± 13 88 ± 11*
Fat-free mass (%) 75 ± 6 64 ± 9 *
Fat-free mass index (kg/m2) 17 ± 3 19 ± 2 *
FEV
1
 (L) 3.1 ± 0.6 3.1 ± 0.5
FEV
 1
 (%pred) 87 ± 32 82 ± 24
FEV
 1
 (% of baseline) 84 ± 14 83 ± 14
Prednisolon (mg/kg) 5 ± 3 5 ± 3
Results are represented as means ± standard deviations; * p < 0.05
In the overweight/obese group only recipients with a weight gain of more than 10% since lung 
transplantation and the actual BMI over 25 kg/m2 in the last six months were selected. The 
normal weight lung transplant recipients were actively matched and had a BMI lower than 25 
kg/m2
 
and a maximal weight gain of 2 kg in the last six months. The two groups were matched 
on basis of the following criteria: disease (COPD or lung fibrosis), gender, age, prescribed 
immunosuppressive medication, including ciclosporine versus tacrolimus and time since lung 
transplantation. Exclusion criteria for both groups were: not able to walk independently, lung 
transplant recipients who had just started a diet or changed their eating habits, and symptoms 
of chronic rejection of the lung (based on the severity of bronchiolitis obliterans syndrome (BOS) 
graded by the recommendations of the International Society for Heart and Lung Transplantation) 
(27). The study protocol was approved by the local ethics committee of the hospital and all 
patients signed an informed consent form. According to Chi-Square power analysis of Portney 
& Watkins (28) a sample size of 42 recipients was needed (df=3, α =<.05, w=.50).
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All lung transplant recipients received postoperative immunosuppression induction consisting of 
rabbit anti-thymocyte globulins (Thymoglobulin) or anti-CD25 monoclonal antibodies (Simulect), 
and maintenance triple immunosuppression with ciclosporine (Neoral) (transplantation era 
1990-2000) or tacrolimus (Prograf) (transplantation era from 2001-2009) plus azathioprine 
(Imuran) or mycophenolate mofetil (Cellcept) plus prednisolone (postoperative dose of 0.2 mg/
kg, tapering to 0.1 mg/kg during the first postoperative year, and further tapering on the long 
term).
Methods
Body composition: Body mass index and fat-free mass.
Bodyweight was measured with a reliable scale (in kilograms) with which BMI was calculated 
(weight in kilograms divided by height in meters squared). Fat-free mass was measured by a 
bioelectrical impedance analysis (Bodystat 1500) and is expressed as percentage of total body 
weight and as fat-free mass index (29).
Daily physical activity.
Performance based daily physical activity was measured by the Digiwalker SW-200 (Yamax; 
Tokyo, Japan). This pedometer has been proved to accurately detect steps taken, as an indication 
of volume of daily physical activity (30). It was proven to have high convergent (r=0.80) and 
discriminative validity (r=0.80-0.90) (31;32). In this study patients were instructed to wear 
the pedometer for ten days (from waking up until going to bed) and to record the number 
of steps per day in a diary. The number of minutes spent swimming, doing fitness or cycling 
were also reported in the diary and were converted into steps. Conversion was based on MET 
(Metabolic Equivalent of Task) per minute of these physical activities (33). For example, 1-minute 
of swimming is about 150 steps, and 1-minute of fitness or cycling is about 100 steps. Steps/day 
including the converted steps was expressed as step equivalents. To exclude a novelty effect, 
the last seven out of ten daily-records were used for further processing.
Questionnaire based daily physical activity was assessed with the Short QUestionnaire to 
ASsess Health-enhancing physical activity (SQUASH) (34). This questionnaire is designed to give 
an indication of the habitual activity level and has shown to be reliable and valid (r = 0.36–0.74) 
(34). It was expressed in total minutes per week and MET/min.
Resting energy expenditure.
Resting energy expenditure was measured using the ventilated-hood technique (35). Criteria 
for valid resting energy expenditure were: a minimum of 15 minutes of steady state and no food 








the standard estimated error had to be smaller than 5% (35). Resting energy expenditure was 
measured for 15 to 20 minutes (35).
Food intake
Food intake was estimated by a trained dietician using an extensive food anamnesis to determine 
the daily amount of food intake, proteins, carbohydrates and fat.
Lower body strength
Lower body strength was assessed using the sit-to-stand test. This test involves counting the 
number of times, within 30 seconds that the patient can come to a full stand from a seated 
position without using his or her arms (36). The 30-second sit-to-stand test has been shown 
to be reliable (test-retest correlation r=0.80) and has been validated against the gold standard 
measure for lower-body strength, the leg-press test (36). According to Jones et al (1999), intra-
class reliability is r=0.89 (test-retest) and criterion validity related to leg press is r=0.77 (test-
retest) (36).
Fatigue
Fatigue based on daily activities in household, body care and social activities was measured with 
the Dutch Exertion Fatigue Scale (DEFS) (37). The Dutch Exertion Fatigue Scale contains nine 
questions, which can be answered on a five-point score ranging from 0 (no) to 4 (yes) (37). A low 
score on the Dutch Exertion Fatigue Scale represents a low score of fatigue in daily activities 
(Cronbach’s alpha 0.91 and Rho 0.91) (37).
Statistical analysis
The statistical program SPSS (version 16.0) was used to analyze the data. Results are presented 
as means ± standard deviation. Post-hoc we decided to split the overweight/obese lung 
transplantation recipients into an overweight and obese group for further analysis. Mann-
Whitney U-tests were used to compare normal weight with overweight//obese lung transplant 
recipients and to compare male with female lung transplant recipients. Multiple regression 
analysis (method forward) was performed to determine contributing variables of overweight and 
obesity in lung fibrosis and COPD lung transplant recipients. BMI was the dependent variable. 
Independent variables were: percentage of fat-free mass, the number of steps per day, resting 
energy expenditure, food calorie intake per day, lower body strength and fatigue. Significance 




Performance based daily physical activity (number of steps/day and step equivalents) was 
significantly higher in normal weight lung transplant recipients as compared to overweight/
obese lung transplant recipients (Table 2). When looking at the overweight (BMI >25 kg/m2) and 
obese (BMI >30 kg/m2) lung transplant recipients separately, the normal weight lung transplant 
recipients had a higher number of step/day and steps equivalents compared to overweight 
lung transplant recipients, though this was not significant. The normal weight lung transplant 
recipients had a higher number of steps/day (figure 1) and a higher number of step equivalents 
compared to obese lung transplant recipients. There was also a significant difference in daily 
physical activity between overweight and obese lung transplant recipients. Questionnaire based 
physical activity was not significantly different between normal weight and overweight/obese 
lung transplant recipients. In normal weight lung transplant recipients men had a lower number 
of steps/day compared to women, though not significant (6692±2050 versus 8667±4689 steps/
day). In overweight/obese lung transplant recipients men had a significantly higher number of 
steps/day compared to women (6510±3241 versus 2408±2233 steps/day, p=0.006).
 
Table 2. Outcome measures of normal weight and overweight/obese lung transplant recipients.









 Steps (steps/day) 7524 ± 3448 4686 ± 3266 * 5919 ± 3826 3146 ± 1481 †
 Steps (equivalents) 9759 ± 3960 6028 ± 3728 * 7348 ± 3797 4378 ± 3102 †
 SQUASH (total min) 1587 ± 952 1506 ± 959 1525 ±1013 1481 ± 949
 SQUASH (MET/min) 5397 ± 4422 5046 ± 2996 5049 ± 2629 5042 ± 3562
Food intake
 Total intake (calories/day) 2532 ± 845 2116 ± 388 2000±386 2259±360
 Proteins (%) 16 ± 3 16 ± 3 16±3 16±3
 Carbohydrates (%) 41 ± 9 41 ± 7 41±6 43±8
 Fat (%) 40 ± 8 42 ± 6 41±6 41±7
 Saturated fat (%) 14 ± 4 16 ± 3 16±3 15±2
Resting Metabolic Rate
 Ventilated Hood (kcal/day) 1506±279 1594±205 1603±177 1580±259
 Ventilated Hood (%pred) 100 ± 14 93 ± 10** 94±8 90±14 ††
Lower body strength
 Sit-to-stand (nr. repetitions) 11 ± 2 10 ± 4 11±3 9±6
Fatigue
 DEFS 7 ± 7 11 ± 10 7±7 16±11 ††
Results are represented as means ± standard deviations; * p=0.01;** p=0.05; differences between the normal 
weight group and overweight/obese group; † p<0.01; †† p<0.05; differences between the normal weight 








Figure 1. Normal weight lung transplant recipients had a higher number of step/day compared to 
overweight lung transplant recipients, though this was not significant. The normal weight lung transplant 
recipients had a significant higher number of steps/day compared to obese lung transplant recipients (p< 
0.01). There was also a significant difference in steps/day between overweight and obese lung transplant 
recipients (p< 0.01).
Resting energy expenditure
There was a significant difference in resting energy expenditure expressed as percentage of 
predicted resting energy expenditure between normal weight and overweight/obese lung 
transplant recipients (Table 2). When looking at the overweight and obese lung transplant 
recipients separately, the predicted resting energy expenditure was significantly higher in the 
normal weight lung transplant recipients compared to the obese lung transplant recipients. The 
resting energy expenditure in normal weight men was significantly higher compared to women 
(1671±211 versus 1299±210 kcal/day, p=0.003).
Food intake
There was no significant difference in food intake between normal weight and overweight/
obese lung transplant recipients (Table 2). There was also no significant difference when the 
overweight/obese group was divided into two groups. The normal weight male lung transplant 
recipients had a higher total food intake compared to women (3067±764 versus 1944±451 
kcal/day, p=0.002).
Lower body strength
Two overweight lung transplant recipients were not able to perform the sit-to-stand test. There 
was no significant difference in lower body strength between normal weight and overweight/
obese lung transplant recipients (Table 2). There was also no significant difference when the 
overweight/obese group was divided into two groups.
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Fatigue
There was no significant difference in fatigue between normal weight and overweight/obese 
lung transplant recipients. The overweight lung transplant recipients had a lower score of 
fatigue compared to the obese lung transplant recipients, though not significant. Fatigue was 
significantly lower in normal weight lung transplant recipients compared to obese lung transplant 
recipients.
BMI and determinants for BMI
BMI was calculated every 3 months in all lung transplant patients. The mean BMI of overweight 
lung transplant recipients continuously increased after transplantation, while the BMI of the 
normal weight group remains relatively stable (Figure 2).
 
Figure 2. BMI before lung transplantation and the change in BMI after transplantation. BMI is expressed 
as mean and 95% confidence interval. Overweight lung transplant patients continue to increase their 
BMI after lung transplantation, while normal weight patients tend to hold on to their BMI after lung 
transplantation. Until 48 months, all patients are included in this figure. There is no difference in the number 
of patients per group over time in this figure.
In order to determine the determinants of BMI, the following variables were included in the 
multiple regression analysis: percentage of fat-free mass, the number of steps per day, resting 
energy expenditure, food calorie intake per day, lower body strength and fatigue. BMI was the 
dependent variable. Determinants for a higher BMI were a lower mean number of steps/day, 
lower percentage of fat-free mass, and lower resting energy expenditure and (Table 3). Together 








Table 3. Multiple regression analysis for the determinants of BMI in lung transplant recipients.
Determinants B Std Error Beta T-value p-value
Constant 39.901 5.468  7.297 <0.001
Fat-free mass (% pred) -.359  .076 -.597 -4.697 <0.001
Ventilated hood (kcal/day) .009  .003  .362  3.091 0.004
Physical activity (steps/day) .000 .000 -.251 -2.061 0.046
R2 = .547
DISCUSSION
This is the first study that systematically investigated the underlying factors of overweight 
in lung transplant recipients by comparing overweight/obese lung transplant recipients with 
matched normal weight recipients. Explaining variables for overweight and obesity in lung 
transplant recipients with lung fibrosis and COPD in this study were a lower percentage of 
fat-free mass, a lower mean number of steps/day, and a lower resting energy expenditure. In 
contrast, food intake, body strength and fatigue did not contribute to the variance in BMI.
The number of steps/day of lung transplant recipients shown in this study is in line with previous 
research (21). Importantly, the number of steps per day was significantly lower in overweight/
obese lung transplant recipients as compared to normal weight lung transplant recipients. 
According to Tudor-Locke and Bassett (2004) the activity scores can be labeled as ‘sedentary’ 
for the obese lung transplant recipients, as ‘low’ for the overweight group, and as ‘somewhat 
active’ for the normal weight group. Whether a lower number of steps per day in overweight/
obese patients is a cause or consequence of high BMI is difficult to determine in this cross-
sectional study. Obviously, a longitudinal study design is needed to prove this. If overweight/
obese lung transplant recipients would increase their number of steps per day to the level of 
normal weight lung transplant recipients, and would stick to their eating habits, it is estimated 
that the BMI would be similar between the two groups after 87 months. Interestingly, the time 
since lung transplantation is also around this amount of months. We suspect that when lung 
transplant patients increase their number of steps/day after transplantation to about 7500 
steps/day, the large increase in BMI after lung transplantation can slowly be reduced. It is 
intriguing that being overweight/obese was associated with self-reported fatigue, which is in 
line with findings in healthy (non lung transplant recipients) individuals (38). In our study, fatigue 
was not associated with daily physical activity (data not shown). Apparently fatigue is not the 
driving force for decreased daily physical activity and higher BMI.
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The questionnaire based daily physical activity was higher, yet non-significant, in the normal 
weight lung transplant recipients compared to the overweight and obese lung transplant 
recipients. Because the SQUASH also assesses household work, this could explain in part why 
the performance-based method demonstrated a significant difference and the questionnaire-
based method did not.
Strikingly, the food intake (kcal/day) of the overweight and obese lung transplant recipients 
is lower though not significant compared to normal weight lung transplant recipients. This 
difference might be explained due to underreported energy intake. For example, one study in 
healthy individuals demonstrated that both men (31-36%) and women (27-32%) underreported 
energy intake based on a food frequency questionnaire (39). Importantly, the percentage of 
underreported energy intake in this study increased with a higher BMI (39). If underreported 
energy intake really matters in our study is questionable, as we did not use a self-administrated 
food questionnaire, but instead a trained and dedicated dietician took the food anamnesis. 
Furthermore, it is conceivable that lung transplant recipients are more eager to care for their 
weight and eating habits because they are frequently seen and alerted by their pulmonary 
physicians.
One of the explaining variables for overweight and obesity in the present study was a lower 
resting energy expenditure. Looking at table 2 it can be acknowledged that subjects with 
overweight/obesity burn more calories per day (due to more bodyweight), yet burn less calories 
per day if expressed by percentage predicted. Apparently, overweight/obese subjects are 
relatively less metabolically active at rest. Indeed the latter fits with the finding of a lower fat 
free mass. Conform these findings, other studies have shown that about 81% of the variability in 
resting energy expenditure can be explained by fat-free mass, fat mass, age and gender (40;41). 
Another explanation for the lower resting energy expenditure found in our overweight/obese 
patients may be their lower physical activity level, as the literature suggests that lower physical 
activity associates with lower resting energy expenditure (42).
A number of methodological characteristics of this study are relevant for a correct interpretation. 
In the overweight group there were some patients with a BMI above 25 kg/m2 (range 19,4-27,3) 
before lung transplantation. For this study we have selected the overweight recipients on basis 
of a weight gain of more than 10% since lung transplantation and an actual BMI over 25 kg/
m2 during at least the last six months. In both the overweight and normal weight group the 








The internal validity of this study is limited, due to the observational nature of the study and its 
small sample size. Nevertheless, this is one of the scarce studies that systematically examined 
the underlying factors of overweight and obesity in a well-characterized group of lung transplant 
recipients. Moreover, we have put much effort in adequately matching normal and overweight/
obese subjects.
In conclusion, our data suggest that overweight/obese lung transplant recipients are less 
physically active as well as having a lower resting metabolism. We believe that the lower 
percentage of fat-free mass is in line with these two findings. Importantly, a higher food intake 
was not significantly contributing to a higher BMI. The clinical relevance of this data is that 
lung transplant recipients should be encouraged to participate in exercise programs after lung 
transplantation and should aim for a rather high daily physical activity level in order to prevent 
the development of overweight or obesity.
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ABSTRACT
Rationale Increased airway obstruction at night or in the early morning is a common symptom 
in asthma and COPD. We hypothesized that this might lead to a shift in sleep timing.
Methods 700 asthma and 500 COPD patients attending the outpatient clinic of the University 
Medical Center Groningen were sent questionnaires about sleep timing (Munich Chronotype 
Questionnaire, MCTQ), sleep quality (Groninger Sleep Quality Scale), daily physical activity 
(Short Questionnaire to Assess Health Enhancing Physical Activity), quality of life (St. George 
Respiratory Questionnaire for COPD patients and Asthma Control Questionnaire for asthma 
patients), and questions about smoking and nocturnal awakening. Sleep timing was compared 
to an age- and sex-matched general population control group.
Results The response rate was 44% for asthma (101 males, 210 females, age 43.4±12.1 years) 
and 50% for COPD patients (140 males, 111 females, age 65.0±8.7). Sleep timing (midsleep on 
free days) was significantly earlier in asthma patients than controls (mean and SD): 4:06 (0:48) 
vs 4:24 (1:24) h (p<0.5), and significantly later in COPD patients than controls (mean and SD): 
3:54 (0:54) vs 3:42 (1:18) h (p≤.05). In asthma, the early timing was significantly associated with 
non-smoking and being physically active. In COPD the late timing was significantly associated 
with smoking.
Discussion This study shows that midsleep on free days and work days is significantly earlier in 
asthma and significantly later in COPD patients as compared to age- and sex-matched controls 
from the general population. We did not find an association between the occurrence of nocturnal 
awakening and sleep timing.
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INTRODUCTION
Accumulating evidence demonstrates substantial and clinically important interactions 
between sleep and disease in patients with obstructive lung disease. In both asthma and 
chronic obstructive pulmonary disease (COPD), these interactions are reciprocal: not only 
can the presence of disease reduce the overall sleep quality, but circadian clock regulation and 
sleep-related changes in respiratory physiology can have a significant impact on the clinical 
presentation of the disease itself (1).
Asthma patients may experience a nocturnal increase in symptoms (cough, wheezing, chest 
tightness) associated with more severe disease (2). This nocturnal worsening of asthma affects 
more than two-thirds of the patients, and contributes importantly to asthma-related morbidity 
and mortality (3). In asthma, the worst symptoms generally occur in the early morning hours 
(4). The occurrence of the nocturnal symptoms is thought to be caused by circadian changes 
in airway resistance, leading to the lowest lung function (FEV
1
) between 3 and 6 AM (1). The 
presence of nocturnal symptoms diminishes the sleep quality of asthma patients (3).
In COPD patients, sleep abnormalities and night-time respiratory symptoms are also common. 
Over 75% of the COPD patients experience night time symptoms (5). The sleep abnormalities 
include symptoms of abnormal breathing, insomnia, excessive daytime sleepiness, and nocturnal 
oxygen desaturation (4, 6). In addition, sleep quality and body transitions have been found to 
be associated with frequent sputum production during the day (7). In most COPD patients, 
the severity of the disease, as measured by FEV
1
, may have only a small effect on overall sleep 
quality. Disruptions in sleep are caused by respiratory symptoms as cough, production of sputum 
and wheezing, nocturnal oxygen desaturation, hypercapnia, and circadian changes in airway 
resistance, as well as side effects of medication (4).
The preferred timing of the sleep-wake rhythm is described in chronotypes. Chronotypes 
represent the preferences in the timing of sleep and wake and are, at least partly, based on 
genetics (8). Early types are more likely to have earlier bedtimes, sleep midpoints, and wake 
times. Late chronotypes are more likely to have late bedtimes, sleep midpoints, and wake times. 
Not surprisingly, there is a large interindividual variation in chronotypes (8, 9). Late types report 
psychological and psychosomatic disturbance more often than do early types and experience 
more mental exhaustion in the evening. Depressed moods shows a high incidence in particularly 
late chronotypes, and late chronotypes consume more stimulants (alcohol and coffee) and are 








In both asthma and COPD patients the quality of sleep can be affected, however the timing 
of the sleep problems seems to differ. Breathing complaints at night are a common symptom 
in asthma; whereas COPD patients often have problems when waking up. In both diseases 
this may theoretically lead to a shift in sleep timing. Besides, since smoking addiction is the 
most frequent cause of COPD and since smokers are more often late chronotypes (10-12), 
the question arises whether late chronotype is more frequently present in COPD patients as 
compared to the general population.
The aim of this study was to assess the distribution of sleep timing in asthma and COPD 
patients compared to a large age- and sex-matched control group from the general population. 
In addition, we aimed to assess the association of sleep timing with: severity/control of disease, 
nocturnal complaints, sleep quality, physical activity, smoking, and medication.
METHODS
Study design
500 COPD and 700 asthma patients attending the outpatient clinic of the University Medical 
Center Groningen were sent questionnaires about sleep timing, sleep quality, daily physical 
activity, quality of life, smoking and nocturnal awakening. Sleep timing was compared to a 
control group from the general population recruited online by the Chronobiology department 
of the University of Groningen and the Chronobiology department of the Ludwig-Maximilians-
University in Munich, Germany. There were two control groups, one for asthma and one for 
COPD. Controls for asthma and COPD were matched for age and sex.
Measurements
The MCTQ was used to assess timing of sleep (8). The questionnaire uses 12 questions about 
sleep times, separated by work and free days, to calculate the midpoint between sleep onset and 
waking (midsleep). When calculating chronotype, midsleep is corrected for potential sleep debt 
on weekdays, age and sex. The MCTQ has been validated with highly significant correlations by 
over 600 sleep-logs, by actimetry, and by correlations to biochemical rhythms such as melatonin 
and cortisol (unpublished data). The MCTQ has also been validated against the widely used 
Morningness-Eveningness Questionnaire (13) showing high correlations (9). The MCTQ has 
proven to be a valid (r=0.915, p<0.001) and reliable (test-retest reliability: r=0.88, p<0.001) 
quantitative tool for the assessment of chronotype (14). Our data is expressed as mid sleep time 
(midpoint between sleep onset and waking).
The Groninger Sleep Quality Scale was used to assess sleep quality (15). The questionnaire 
contains 14 false/true questions about the previous night and the feeling of well-being in the 
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morning. The measurement is a score derived from 14 questions, ranging from good sleep 
(score=0) to worst possible sleep (score=14). A score of 6 or higher indicates disrupted sleep. 
In addition, the questionnaire consists of specific questions about the time needed to fall asleep, 
number of awakenings during the night and sleep duration in hours. The questionnaire was 
validated in 80 depressed inpatients, the mean score on the scale was 6.0 (±4.2) and Cronbach’s 
alpha for internal consistency was 0.88 (15, 16).
The Short Questionnaire to Assess Health enhancing physical activity (SQUASH) was used to 
assess daily physical activity (17). This questionnaire contains questions on habitual activities 
with respect to occupation, leisure time, household, transportation means and other daily 
activities. Total minutes of activity are calculated for each question by multiplying frequency 
(days/week) by duration (min/day). The answers on the questions are individually coupled with 
an intensity score and the sum of these scores is taken to establish a weekly activity score. The 
SQUASH is a reliable (overall reproducibility: r
Spearman
=0.58, p<0.0001) and reasonably valid 
(SQUASH versus CSA Activity monitor: r
Spearman
=0.45, p=0.005) questionnaire (17).
The St. George’s Respiratory Questionnaire was used to assess disease-related quality of life in 
COPD patients (18). Within this questionnaire 3 component scores are calculated: symptoms, 
activity and impact on daily life; a total score was calculated based on the 3 components. SGRQ 
scores correlate with appropriate comparison measures and are a valid measure of impaired 
health in subjects with chronic airflow limitation that is repeatable and sensitive. The validity 
was originally tested in a study of 141 patients, symptom score versus frequency of wheeze (r2 = 
0.32, p < 0.0001); activity versus 6-min walking distance (r2 = 0.50, p < 0.0001); impact versus 
anxiety (r2 = 0.38, p <0.0001) (18).
The Asthma Control Test (ACT) was used to assess quality of life in asthma patients (19). The 
ACT was developed as a screening tool to assess asthma control in adolescents and adults. The 
test consists of 5 items that assess activity limitation, shortness of breath, night-time symptoms, 
use of rescue medications, and patients overall rating of asthma control over the previous 4 
weeks. The questions are scored from 1 (worst) to 5 (best); to assess a total ACT score the sum 
of the 5 questions are calculated. An ACT score above 20 indicates well controlled asthma. The 
ACT was shown to be reliable and valid (19-21).
Statistical analyses
The statistical program SPSS (version 23.0) was used for statistical analyses. Assumption 
of normality was tested using the Shapiro-Wilk test. Means and standard deviations (SD) 
were calculated for normally distributed parameters, and median (ranges) for non-normally 








and COPD patients and to compare measures in asthma and COPD patients with controls. 
Within the groups of asthma and COPD patients, correlations between different variables 
were analyzed using Pearson correlations for normally distributed parameters and Spearman 
correlations for non-normally distributed parameters. To assess the determinants of sleep 
timing, a multiple linear regression analysis was used.
RESULTS
Participants
The response rate was 44% for asthma and 50% for COPD. Characteristics of the 311 asthma 
patients, 251 COPD patients and their age and sex matched control groups are shown in table 1.
 









Age (year) 43 ± 12 43 ± 12.1 65 ± 8.8 65 ± 8.6
Gender (% M/F) 31/69 32/68 56/44 56/44
Body Mass Index (kg/m2) 26 ± 4.9 25 ± 4.6 26 ± 5.6 26 ± 3.8
FEV
1 
(%predicted) Not available Not available 62 ± 22.9 Not available
Smoking (% yes) 15% 27% 23% 9%
Sleep Medication (% yes) 1% 5% 22% 11%
Pulmonary Medication (% yes)
Long-acting Bronchodilator











Sleep timing in asthma and COPD
Midsleep on free days and work days was significantly earlier in asthma and significantly later in 
COPD patients as compared to their controls (figure 1). When corrected for sleep, age and sex 
(chronotype), asthma patients had a significantly earlier midsleep compared to COPD patients 
(3h18 vs 3h48, t-test p<.001). Midsleep on free days becomes earlier with a higher age (figure 
2). The results of the MCTQ are shown in table 2, figures 1 and 2 and figure S1.
A multiple linear regression analysis was performed to assess which determinants affect the 
sleep timing on free days of asthma and COPD patients. The following variables were included: 
age, gender, smoking, sleep quality, nocturnal complaints and daily physical activity (minutes/
week). In COPD, only age (ß -0.022) was a significant variable in the variance in midsleep; 
midsleep on free days is earlier in older COPD patients. In asthma, smoking (ß 0.54), age (ß 
-0.013), and daily physical activity (ß -.00007) were significant variables; midsleep on free days 
was earlier in non-smoking asthma patients, in older asthma patients, and in physically active 
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asthma patients. Smoking is asthma was by far the most important significant contributor in 
the variance of midsleep.
 
 
Figure 1.  Midsleep on free days in COPD, asthma and their controls
Midsleep (the midpoint between sleep onset and waking) on free days was significantly earlier in asthma 






















































































































































































































































































































































































































































































































































































































































































































Associations with Sleep timing
Awakening associated with nocturnal complaints
54% of the asthma patients and 34% of the COPD patients reported awakenings during the 
night associated with nocturnal complaints. Awakenings due to nocturnal complaints did 
not associate significantly with the variation of sleep timing (table S1). In COPD patients, the 
occurrence of nocturnal awakening was significantly associated with an earlier chronotype 
(3h42 vs 4h00, t-test p≤.05).
In asthma, there were associations between the occurrence of nocturnal awakening and lower 
sleep quality (Chi-square value 15.39, df 2, p≤.001) and lower asthma control (Chi-square value 
53.26, df 1, p≤.001). Also COPD patients who reported nocturnal awakening reported a lower 
sleep quality (Chi-square value 14.48, df 2, p≤.001).
Smoking
Smoking (current versus non-current smoking)was associated with a later midsleep on free days 
in both asthma and COPD (4h36 vs 4h02, t-test p≤.05 and 4h11 vs 3h49, p<.001 respectively). 
This trend was also seen in the asthma control group (5h20 vs 4h09, t-test p≤.001), but not in 
the COPD control group (figure S2). There were no significant differences between the smoking 
and non-smoking groups regarding age or sex.
Use of medication
Only 4 asthma patients used sleep medication. Therefore, we did not analyze the associations 
between midsleep and sleep medication in asthma. Asthma patients who were using inhaled or 
oral corticosteroids, were later chronotypes (midsleep on free days corrected for sleep, age and 
sex) than those who were not using corticosteroids (3h20 vs 3h05, t-test p≤.05).
In COPD, there were no significant associations between the usage of sleep medication and 
sleep timing. In COPD controls, an earlier sleep end on work and free days (5h39 vs 6h32, t-test 
p≤.05 and 6h27 vs 7h35, p≤.05 respectively) and a shorter sleep duration on free days was 
associated with the usage of sleep medication (6h27 vs 7h32, t-test p≤.05). Also, COPD controls 
who used sleep medication spent more time in bed between waking up and getting up on free 
days than those who did not use sleep medication (26 minutes vs 13 minutes, t-test p≤.05).
Sleep quality
In asthma patients, 51% qualified his/her sleep quality as ‘good’, 26% as ‘moderate’ and 23% 
as bad. In COPD patients, 42% qualified his/her sleep quality as ‘good’, 25% as ‘moderate’ and 
33% as bad. Asthma patients experienced a significantly better sleep quality as compared to 








and sleep timing in asthma or COPD patients. In both asthma and COPD patients a shorter 
average sleep duration was associated with a lower sleep quality (r=-.114; p≤.05 and r=-.229; 
p≤.001 respectively).
Daily physical activity
Asthma patients spent significantly more time being physically active compared to COPD 
patients (2671 ± 1237.2 min/week versus 1196 ± 1187.0 min/week respectively; p≤.001). The 
intensity of physical activity (determined as MET*min/week) was also significantly higher in 
asthma patients compared to COPD (7790 ± 4223.9 MET*min/week versus 4419 ± 4556.8 
MET*min/week respectively; p≤.001). Of the asthma patients, 66% complied with the American 
College for Sports Medicine (ACMS) guideline of 30 minutes of moderate-intensity daily 
physical activity during at least five days a week. In COPD, 49% complied with this guideline. 
There were no significant associations between physical activity and sleep timing in COPD. In 
asthma patients, a higher intensity of physical activity was associated with an earlier chronotype 
(R=-.134 p≤.05) (figure S3). Asthma patients who did not comply with the ACSM guideline had 
a shorter sleep duration (6h54 vs 6h37, t-test p≤.05) (figure S4).
Quality of life
In asthma patients, 76% reported ‘good’ asthma control (measured with the ACT). Asthma 
patients who reported ‘poor’ asthma control tended to have an earlier midsleep on free days 
than patients with ‘good’ asthma control (3h56 vs 4h10, t-test p=.093). The mean total score 
of the Saint George Respiratory Questionnaire to assess quality of life in COPD patients was 
44.4 ± 18.5. There were no significant correlations with quality of life in COPD patients and 
sleep related outcomes.
DISCUSSION
This study shows that midsleep on free days and work days is significantly earlier in asthma and 
significantly later in COPD patients as compared to their age- and sex-matched controls from 
the general population. In asthma, the early timing was significantly associated with non-smoking 
and being physically active. In COPD the late timing was significantly associated with smoking.
Sleep timing of asthma patients
The sleep timing of asthma patients is significantly earlier as compared to an age- and sex-
matched general population. The differences are significant for almost all sleep timing variables. 
Strikingly we found no significant difference between the sleep timing of asthmatics with 
nocturnal complaints and those without nocturnal complaints. We expected a shift in patients 
with nocturnal symptoms (cough, wheezing, chest tightness) as they may experience increased 
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airway obstruction mostly between 3:00 and 6:00 AM (4). Our results contrast with a previous 
study of Ferraz and colleagues showing that there was no difference in chronotype distribution 
between patients with nocturnal asthma as compared to non-asthma controls (22). Additionally, 
Ferraz and colleagues showed that there were less early chronotypes in patients with nocturnal 
asthma compared to patients without nocturnal worsening (22). These contrasting results in 
outcome could be due to a different questionnaire that was used or to absence of matching of 
patients and controls in the study by Ferraz and colleagues.
Although we could not demonstrate an association between sleep timing and nocturnal 
complaints we showed that the presence of nocturnal symptoms diminishes the sleep quality 
of asthma patients. This is in line with a large prospective clinical trial that found an association 
between sleep disturbances and poor sleep quality in asthma patients (23). In our study, 
asthmatics with a lower sleep quality had a shorter sleep duration, and were more likely to use 
corticosteroids. In asthma patients who used corticosteroids, the sleep timing as expressed 
by chronotype (midsleep on free days corrected for sleep, age and sex) was later as compared 
to non-corticosteroid users. Nocturnal awakening was not only significantly associated with a 
poor score on sleep quality and with the usage of corticosteroids, but also with worse asthma 
control. We speculate that patients who experience low asthma control, are most likely using 
more corticosteroids and experience more nocturnal arousal.
In addition to disease-related variables, behavioural habits like smoking and physical activity 
were also assessed in this study. A large European population-based cohort study showed that 
the prevalence of smoking in asthmatics (26%) is relatively close to that found in the general 
population (30%) (24). In our study, we found that asthma patients were less likely smokers, as 
compared to the general age- and sex-matched population. Asthmatics who smoke were more 
likely to have later sleep timing. Most (66%) asthma patients complied with the American College 
for Sports Medicine guideline of 30 minutes of moderate-intensity daily physical activity five 
days a week. A higher activity score was associated with earlier midsleep on free days and with 
an earlier chronotype. This is in line with a large questionnaire based population study, in which 
higher leisure time activity levels were associated with normal and sufficient sleep and in which 
low levels of leisure time activity were associated with evening type sleepers (25).
Sleep timing of COPD patients
The sleep timing of COPD patients was significantly later as compared to an age- and sex-
matched general population. We hypothesized that the timing of sleep could be shifted due 
to disease factors as COPD patients often experience sleep difficulties related to sputum 
production and cough (1, 5, 7). Although the quality of sleep is associated with disease severity 








severity defined by the level of airflow obstruction and the symptoms scale of the Saint George 
Respiratory Questionnaire. About thirty percent of the COPD patients reported nocturnal 
awakening. These patients reported a lower sleep quality and were more likely to have an earlier 
sleep timing (expressed as chronotype) than those without nocturnal awakening. Apparently 
this subgroup of COPD patients tries to shift their sleep timing to an earlier timing as compared 
to COPD patients who do not experience nocturnal awakening and who experience good sleep 
quality.
In the general population, unhealthy behavior, like smoking and drinking alcohol, is related to 
having a late chronotype and social jetlag (12). Since COPD is a smoking related disease we 
hypothesized that COPD patients might have a later chronotype. In this study we found that 
late chronotype, midsleep and social jetlag (data not shown) in our COPD population was indeed 
associated with smoking behaviour.
Another indication for unhealthy behaviour is the level of physical activity. In COPD patients, 
physical activity level was also low. Only 49% of the COPD patients complied with the American 
College for Sports Medicine guideline of 30 minutes of moderate-intensity daily physical activity 
five days a week. In this study, no associations were found between physical activity parameters 
and sleep timing. This is in line with a previous study on sleep/wake cycle and physical activity 
in healthy elderly by Ceolim and Barreto (2000) (27). Interestingly, in a COPD group, Soler 
and colleagues found an improvement in sleep quality after pulmonary rehabilitation (28). The 
influence of physical activity on sleep timing and quality needs further investigation, as it might 
be an important strategy to improve the sleep quality of COPD patients.
Limitations
The control group data was assessed via the internet, on a voluntary basis, which may introduce 
a selection bias. Also, it is not certain if the control group is actually a healthy control group. In 
addition, in the control group the data on smoking and (sleep) medication was not complete for all 
controls. Pulmonary function data was not available for the asthma group. An important factor 
contributing to chronotype is light environment (8). When experiencing major disturbances at 
night you may be giving yourself light exposure in the night when you should be experiencing 
darkness. This could influence the entrained phase of the biologic clock. In this study the 
exposure to light at night was not measured. Whether light exposure at night is influencing the 
timing of sleep in COPD and asthma patients should be addressed in future studies. Physical 
activity data was assessed using a questionnaire, however in a previous study we concluded 
that patients with COPD report more physical activities when assessed with a questionnaire 
as compared to performance based measures (29). We hypothesized that COPD patients might 
be more aware of low intensity or short duration physical activities, which are neglected by 
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non-COPD patients. In the current study, this overestimation in COPD patients might also be 
present. Finally, most correlations are modest.
Conclusions
This study showed that there is a shift in sleep timing, as indicated by midsleep on free days, in 
asthma and COPD patients. Asthma patients tend to sleep earlier and COPD patients tend to 
sleep later when compared to an age- and sex-matched general control population.
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Figure S1. Histogram Midsleep on free days
Figure S2. Midsleep associations with smoking  
Smoking was associated with a later midsleep on free days in both asthma and COPD (t-test p≤.05 and 
p<.001respectively). This trend was also seen in the asthma control group (t-test p≤.001), but not in the 








Figure S3. Chronotype association with physical activity in asthma 
High intensity of physical activity was associated with an earlier chronotype (midsleep corrected for sleep, 
age and sex) (R=-.134, p≤.05).
Figure S4. Sleep duration and complying with physical activity recommendation in asthma
Asthma patients who do not comply with the American College for Sports and Medicine guideline of 30 
minutes of moderate intensity daily physical activity during at least 5 days a week tended to have a shorter 
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ABSTRACT
To measure activity during sleep polysomnography and actigraphy are often used. Recently 
the DynaPort MiniMod is developed, which measures movement intensity and body position 
at day and night. The aim of this study was to examine the validity of the DynaPort MiniMod in 
accessing physical activity and body posture during sleep. In Study A 10 healthy participants slept 
with the DynaPort MiniMod and the Actiwatch for one night. In Study B 8 subjects suspected 
for Obstructive Sleep Apnoea Syndrome slept for one night with the DynaPort MiniMod 
and underwent complete polysomnography as a usual care protocol. In Study A a significant 
moderate inter-method correlation (r=.70) was calculated between the movement scores of 
the Actiwatch and the DynaPort MiniMod. Study B demonstrated a high intraclass correlation 
(r=.84) between the body posture scores of the DynaPort MiniMod and the polysomnography 
position sensor. The DynaPort MiniMod demonstrates high validity in measuring accessory 
physical activity during sleep.
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INTRODUCTION
Disruptions in sleep occur in any condition in which sleep doesn’t follow the normal sleep-wake 
cycles or a particular sleep cycle does not last as long as it should. Sources of sleep disruption 
could vary from bad sleep hygiene and stressful life events to the use of drugs, tobacco, or 
alcohol, or be related to mood disturbances such as depression and possibly sedentariness. 
While lying awake, physical activity during the night could be increased. Disruptions in sleep 
could also affect amount of daily physical activity during the day and affect the perceived 
quality of life (1). Obstructive Sleep Apnoea, a sleep disorder characterized by severe pauses 
in breathing during sleep, is the most common type of a sleep disorder.
To examine sleep problems it is relevant to register disruptions in the sleep/wake cycle and 
movements during the night. This can be measured with a number of devices. Polysomnography 
is the current gold standard in measuring sleep. It registers the sleep pattern by an ambulant 
sleep system with 12 different channels (2). But it is not always practical for 24-hours or longer 
recording (3). In addition, it is expensive and recording requires professional placement and use 
(4). Actigraphy is one of the most frequently used devices in sleep research. Actigraphy is a reliable 
instrument for assessing sleep and wakefulness (5;6). The Actiwatch, worn on the wrist, is a 
device used to estimate sleep and wakefulness based on motor activity of the upper extremity 
(7). The advantages of actigraphy are its relatively low cost and the Actiwatch can conveniently 
record sleep at night continuously up to several weeks (4). Comparison of actigraphy with 
polysomnography, the ‘gold standard’, has yielded agreement rates in the range of 78 to 95% 
(8). Actigraphy was valid for assessing sleep durations and sleep/wake activity, but less reliable 
for more specific measures such as sleep offset or sleep efficiency (4). The disadvantages of 
actigraphy are that it is a device which measures one dimension (4). There is no information given 
about which body posture and little information about the intensity of movements.
Polysomnography is difficult to use in sleep-related field studies and actigraphy measures provide 
no specific information about body posture. To evaluate subtle changes in body position and 
possibly related sleep disruptions, a device is needed which measures accurately body position 
and movement intensity over a longer period, including the sleep period. In this respect the 
DynaPort MiniMod (McRoberts BV, the Hague, the Netherlands) seems a more useful device. 
The DynaPort MiniMod is a tri-axial accelerometer especially designed to measure intensity of 
movements and to register position of the human body with respect to gravitation, which ensures 
a realistic picture of all physical activities (9). With little adjustment, the device is able to assess 
exact position and hence movement during sleep. To our knowledge, until now the DynaPort 
MiniMod has only been used once before in sleep research. In this study physical activity was 








The aim of this study was to examine the validity of the DynaPort MiniMod in accessing body 
posture and physical activity during sleep. Study A focused on the correlation between the 
movement times measured by the DynaPort MiniMod and the Actiwatch in healthy adults and 





The movement analyses were assessed non-invasively using an Actiwatch (Actiwatch AW 7, 
Cambridge Neurotechnology, Cambridge, UK). The Actiwatch has the size and shape of a watch 
and is worn on the nondominant wrist to register acceleration-induced wrist movements. The 
Actiwatch quantifies accelerations due to motor activity of the arm and integrates these over 
30-second periods. “Practice guidelines for Actigraphy” established by the Standards of Practice 
Committee of the American Academy of Sleep Medicine state actigraphy testing is reliable and 
valid in normal, healthy populations (8;11).
Polysomnography.¾ 
Polysomnographic examination was conducted by the ambulatory use of an Embla A10 digital 
recorder (Medcare, Reykjavik, Iceland). To stage sleep according to standardized criteria, surface 
electroencephalography (EEG), submental and leg (tibial anterior muscle) electromyography 
(EMG), as well as left and right electrooculography (EOG) were used. A pulsoximeter (Oximeter 
Flex Sensor—8000J-3, Medcare, Reykjavik, Iceland) recorded oxyhemoglobin saturation (SaO2) 
and electrocardiography (ECG) monitored the cardiac function. Oronasal airflow was recorded 
with a pressure cannula, respiratory effort by thoracic and abdominal strain gauges. An anterior 
tibial EMG was recorded to screen for periodic limb movements and analog output of a body 
position sensor in three directions was monitored (12-14).
Accelerometry.¾
Accelerations were measured by the DynaPort MiniMod, a small and lightweight measurement 
device (5.6 cm × 6.1 cm × 1.5 cm, 54 g; McRoberts BV, The Hague, The Netherlands). It consists 
of three orthogonally mounted accelerometers and has a local memory card for data storage. 
Data was collected at 100 Hz and stored on a Secure Digital Memory Card. The DynaPort 
MiniMod was firmly fixed in a belt, which was worn above the nightclothes around the trunk at 
the back (15). Under controlled conditions, performed in a shaker device, the results obtained 
by the DynaPort MiniMod are highly reproducible (by intraclass correlation coefficients 0.97, 




The DynaPort MiniMod was compared with the Actiwatch in 10 healthy subjects, 3 males and 7 
females with a mean age of 26 (standard deviation = 14, range 13-54) years. Participants wore 
both devices during one night sleep at home. The devices differ in detection and presentation of 
movements, but do measure movement time in seconds during sleep. The DynaPort MiniMod 
was positioned at the back and assesses movement time in seconds based on the changes in 
gravitation measured with 100 Hz. The Actiwatch measures a movement score every 30 seconds 
based on the motor activity around the wrist. The movement time of the DynaPort MiniMod 
and the movement score of the Actiwatch were synchronized per minute for each participant. 
To compare these two datasets the sum score of every previous 10 minutes was calculated per 
minute for both devices. The outcome of the Actiwatch is the number of movement scores per 
minute and of the DynaPort is the movement time in seconds per minute. The Actiwatch and 
DynaPort MiniMod were started and stopped simultaneously. Participants recorded in a diary 
the time starting and stopping devices and the time spending in and out of bed. The participants 
were free to choose their own bed and awakening time. The next morning the data stored on 
the memory card of the DynaPort MiniMod and actigraphy were transferred to a laptop.
Study B.¾
The DynaPort MiniMod was compared with the position sensor of the polysomnography in 8 
patients suspected of obstructive sleep apnoea syndrome, 5 males and 3 females with a mean 
age 50 years (standard deviation = 12, range 29-69). The participants were pulmonary out-clinic 
patients recruited from the University Medical Center Groningen. Participants wore both devices 
at home during a period of 20 to 22 hours including sleep during one night. Both devices detect 
body posture per second, and measure postures during lying down for the back, front, left, and 
right, respectively. The outcome for both methods is position per second. The dataset of the 
DynaPort MiniMod and the position sensor of the polysomnography were synchronized per 
second for each participant. Polysomnography and the DynaPort MiniMod measures were started 
simultaneously at the Department of Clinical Neurophysiology of the University Medical Center 
Groningen. Participants marked the time from getting to bed until waking up, only the night time 
registrations were used for analysis. Participants were free to choose their own bed and awakening 
time and were instructed to stop wearing the DynaPort MiniMod in case the device was perceived 
as unpleasant to wear. The next morning participants came to the hospital where the devices 
were removed and the obtained data stored on the memory card were transferred to a computer.
 
Statistical analysis
The Actiwatch and DynaPort MiniMod data were synchronized for each participant. The sum 








minute for both methods. The DynaPort MiniMod and the polysomnography both gave the 
body position for every second. Missing position outcomes were filled in as unknown. All analyses 
were conducted using the Statistical Package for Social Sciences (SPSS 16.0) for windows. 
Coefficients of interest were analyzed as means and standard deviations. For Study A correlations 
were calculated to measure inter method (device) agreement. For Study B intraclass correlation 
coefficients (ICC) were calculated to measure reproducibility of replicated measures from the 
same participant. Cronbach alpha was calculated to asses internal consistency. According to 
Fleiss (1986) intraclass correlation smaller than 0.4 indicates reproducibility as poor, between 
0.4 and 0.75 as good, and larger than 0.75 as excellent. As the significance level p < .05 was taken.
RESULTS
Study A: DynaPort MiniMod and Actiwatch
Visual inspection of the DynaPort MiniMod and the Actiwatch registrations of the 10 healthy 
participants showed a highly comparable pattern over time within individuals. An example of 
the sum results of a participant wearing the DynaPort MiniMod and Actiwatch during the night 
is shown in Figure 1. In total 4434 movement-scores were analyzed; mean number for each 
participant was 443 movement-scores (standard deviation = .82).
The reliability and internal consistency between the DynaPort MiniMod and the Actiwatch are 
given by Table 1. The correlations for the ten participants ranged from .51 to .91, with a mean 
of .75 (standard deviation=.11). The overall correlation coefficient for the ten measurements 
(4434 scores) is .70. Cronbach alpha ranged from .67 to .95, for the mean sum score Cronbach 
alpha was .82.
Figure 1. Study A. Example of the Actigraph movement score and the DynaPort MiniMod movement time. 



















































































































































































































































































































































































































































































































































































































































































Study B: DynaPort MiniMod and Polysomnography Position Sensor
The analysis of the DynaPort MiniMod and the polysomnography position sensor registrations 
of the eight participants suspected for Obstructive Sleep Apnoea were based on body posture 
per second, specified in four possible postures during lying down, namely, back, front, left, and 
right (see Table 2 and Fig. 2).
The reliability and internal consistency between the DynaPort MiniMod and the 
polysomnography position sensor are given by Table 3. The ICC ranged between .66 and 
.95 with mean .84 and standard deviation = .11. ICC for eight nights (total seconds in which 
movement scores are recorded: 270774 seconds) was .84. Cronbach alpha ranged between 
.66 and .95; the mean Cronbach alpha was .84.
Figure 2. Study B. Body posture registered by the DynaPort MiniMod and the Polysomnography position 
sensor. The Horizontal line indicates the time in seconds. The body posture is scaled 1 to 5, 1 to 4 are lying 
down positions. 1: back, 2: front, 3: left and 4: right. Scale 5 represents all other positions described as 
unknown.
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Table 2. Percentage of Positions Taken (Back, Front, Left, Right and Unkown) During one Night with the 
DynaPort MiniMod (DP) and the Polysomnography Position Sensor (PPS)










1 DP 40807 93.7 0.0 0.0 0.0 6.3
PPS 94.3 0.2 0.1 0.0 5.4
2 DP 30442 40.3 0.0 11.6 47.6 0.5
PPS 42.1 1.2 11.3 44.6 0.8
3 DP 32254 46.8 0.0 5.3 39.5 8.4
PPS 29.2 3.0 14.4 39.6 13.8
4 DP 30432 22.3 0.4 54.2 20.2 2.9
PPS 36.4 1.1 40.2 18.9 3.4
5 DP 35926 47.9 0.0 4.6 46.2 1.3
PPS 45.4 0.2 4.6 45.5 4.3
6 DP 40618 51.9 2.0 13.9 30.2 2.0
PPS 39.0 2.1 13.9 30.1 14.9
7 DP 34383 72.2 0.0 26.9 0.0 0.9
PPS 54.9 3.8 16.0 16.3 9.0
8 DP 25912 72.0 0.0 20.8 3.8 3.4
PPS 70.6 3.8 11.3 13.2 1.1
Table 3. Participants Characteristics, Intraclass Correlation, and Cronbach Alpha for Study B: Comparison 
of Body Posture Detected by Polysomnography and DynaPort MiniMod during 1 Night in 8 Patients 
Suspected of Obstructive Sleep Apnea Syndrome






1 M 69 36 40807 .95* .95
2 M 42 37 30442 .94* .94
3 M 58 27 32254 .75* .75
4 F 50 41 30432 .86* .86
5 M 52 35 35926 .90* .90
6 F 29 26 40618 .72* .72
7 F 50 30 34383 .66* .66
8 M 42 31 25912 .89* .89
Total    270774
Mean .84* .84








Feasibility of the DynaPort MiniMod
The feasibility of the DynaPort MiniMod in measuring position during sleep was examined. 
None of the participants stopped wearing the DynaPort MiniMod, it can be concluded that the 
device was not unpleasant for the participants to wear during a night. The sleep reports were 
easy to interpret. If a participant was not lying down, the position was reported as ‘missing’. 
Polysomnography gives the position different than lying down the code ‘unknown’. Missing 
values in the DynaPort MiniMod data were interpreted as unknown. Data analyses showed 
in polysomnographic data a mean of 6.6% unknown and 3.2% of the data measured with the 
DynaPort MiniMod.
DISCUSSION
In this study the validity, reliability and feasibility of the DynaPort MiniMod in assessing 
physical activity during sleep was examined. In 10 healthy subjects the DynaPort MiniMod 
demonstrated a significant correlation (r=.70) with actigraphy during one night sleep at home. 
In eight subjects suspected for Obstructive Sleep Apnoea Syndrome data of the DynaPort 
MiniMod gave a significant correlation (ICC=.84) with data of the polysomnography position 
sensor during one night sleep at home. Cronbach alpha in both studies showed satisfactory 
high internal consistency (Study A α = .82; Study B α = .84). The DynaPort MiniMod is valid 
and feasible in assessing intensity of physical activity and changes of body position during sleep.
A methodological issue relevant for the interpretation of the data is the different positions of the 
DynaPort MiniMod and Actiwatch on the body. The DynaPort MiniMod is placed on the back of 
the trunk, while the Actiwatch is worn at the wrist. One might anticipate movements of the wrist 
to differ significantly from movements of the trunk, however Kushida, et al. showed actigraphy 
and polysomnography registered the same type and number of movements (8). This is consistent 
with Littner, et al. who reported no difference between movement detections collected from 
actigraphy placed at different locations (e.g., dominant wrist, nondominant wrist, ankle, or trunk) 
(11). The use of the Actiwatch in this study was suitable for validating the DynaPort MiniMod.
By comparing the DynaPort MiniMod with the Actiwatch and the polysomnography position 
sensor a number of registration problems occurred. Both the Actiwatch and polysomnography 
disposed an internal clock running parallel to the connected computer. The DynaPort MiniMod 
does not have an internal clock which runs parallel to the connected computer. The DynaPort 
MiniMod primarily recons the recorded time. The absence of a parallel running internal clock in 
the DynaPort MiniMod could affect the synchronization of the results because an exact point 
to start measuring is lacking. To this synchronization problem of the DynaPort MiniMod and 
Actiwatch, both devices were started at the same clock time for every measurement.
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Another synchronization problem occurred with the measured timeframe. The Actiwatch 
measured a timeframe of 30 seconds (2 Hz) and the DynaPort MiniMod one of 100 Hz. It was 
not possible to synchronize on the exact second between these two devices. In contrast, the 
DynaPort MiniMod and polysomnography position sensor could be synchronized on the second.
In this study a heterogeneous group of participants was included by age and sex. Nevertheless, 
age and sex did not seem to confound data. All participants were informed about the use of the 
DynaPort MiniMod and the Actiwatch in the same way.
The feasibility of the DynaPort MiniMod was evaluated after completing data collection and 
processing. It turned out the DynaPort MiniMod is suitable to wear. The DynaPort MiniMod 
is also useful in measuring activity during sleep of overweight participants, since there were 
no differences in outcomes between participants who were overweight and average weight.
In conclusion, this study examined the validity of the DynaPort MiniMod in accessing physical 
activity and changes in body position during sleep. The DynaPort MiniMod was significantly 
moderately correlated with actigraphy during a one night sleep at home in a small number of 
healthy participants. The DynaPort MiniMod was highly correlated with body position detected 
by polysomnography in a small number of subjects suspected of Obstructive Sleep Apnoea 
Syndrome. This suggests the DynaPort MiniMod can be a useful in recording physical activity 
during night as well as during day. A potential shortcoming for sleep studies is the lack of an 
internal clock. This should be improved before carrying out further sleep validation studies with 
other patient groups and larger size.
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SUMMARY OF THE STUDIES IN THIS THESIS
In chapter 2 we systematically reviewed the literature on daily physical activity in patients with 
COPD, categorized in performance-, questionnaire- and interview-based daily physical activity. 
The results of chapter 2 demonstrated that daily physical activity for patients with COPD was 
lower than in healthy controls and lower than what the international guidelines recommend to 
maintain or enhance physical health and fitness. This lower level of daily physical activity for 
patients with COPD was associated with a higher level of airway obstruction, a lower level of 
physical fitness, and higher levels of systemic inflammation.
In chapter 3 we examined daily physical activity in a performance and self reported fashion 
in patients with COPD divided over the 3 echelons of healthcare. The aim of this chapter was 
to assess daily physical activity and its associations with several physiological, functional and 
psychological variables in a broad group of patients with COPD. We showed that daily physical 
activity in our study population was low. Daily physical activity was significantly associated with 
variables reflecting functional capacity (performance based and self reported), and with the 
psychological variables depression and self efficacy. A structural equations model demonstrated 
that psychological variables indirectly affect daily physical activity, through variables reflecting 
functional capacity.
In chapter 4, we examined the effect of a pedometer-based exercise counseling strategy to 
enhance daily physical activity on steps/day, fitness and HRQOL of stage I-III COPD patients. 
Results showed that this strategy is feasible and effective in out clinic patients who are not 
participating in a rehabilitation program. This study demonstrated that daily physical activity 
(steps/day), physical fitness, health-related quality of life and intrinsic motivation improved 
statistically significantly after 12 weeks of intervention.
In chapter 5, we showed that daily physical activity was significantly higher in COPD lung 
transplant recipients compared with COPD lung transplant candidates. Lower-body strength, 
and higher pulmonary function and number of months after transplantation contributed 
significantly to a higher daily physical activity level of lung transplant recipients. No significant 
relation between daily physical activity and fear of physical activity and motivation to exercise 
was found in this study.
To our knowledge, chapter 6 is the first study that systematically investigated the underlying 
factors of overweight in lung transplant recipients by comparing overweight/obese lung 
transplant recipients with matched normal weight recipients. Explanatory variables for 
overweight and obesity in lung transplant recipients with lung fibrosis and COPD in this study 
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were a lower percentage of fat-free mass, a lower mean number of steps/day, and a lower resting 
energy expenditure. In contrast, food intake, body strength and fatigue did not contribute to 
the variance in BMI.
In chapter 7 we studied the variation of midsleep and chronotype distribution of asthma and 
patients with COPD compared to age and sex matched general population controls. Compared 
to controls, sleep timing was significantly earlier in asthma and later in COPD. In asthma, the 
early timing was significantly associated with non-smoking and being physically active. In COPD 
the late timing was significantly associated with smoking.
In chapter 8 the validity, reliability and feasibility of the DynaPort MiniMod in assessing 
physical activity during sleep was examined. In 10 healthy subjects the DynaPort MiniMod 
demonstrated a significant correlation (r=.70) with actigraphy during one night sleep at home. 
In eight subjects suspected for Obstructive Sleep Apnoea Syndrome data of the DynaPort 
MiniMod gave a significant correlation (ICC=.84) with data of the polysomnography position 
sensor during one night sleep at home. Cronbach alpha in both studies showed satisfactory 
high internal consistency (Study A α = .82; Study B α = .84). The DynaPort MiniMod is valid 
and feasible in assessing intensity of physical activity and changes of body position during sleep.
DISCUSSION
The main aim of this thesis was to examine daily physical activity in patients with COPD and to 
determine which determinants contribute to the variation in the level of daily physical activity 
in pulmonary patients, especially in patients with COPD.
Daily physical activity in patients with COPD
Daily physical activity level
In this thesis the level of daily physical activity of patients with COPD was systematically 
reviewed. Both performance- and questionnaire based instruments demonstrate a large 
variability in the level of daily physical activity in patients with COPD. This variability was 
observed in the systematic review, and in the different chapters of this thesis, even when 
measured with the same measurement tool.
The level of daily physical activity in patients with COPD was assessed in a performance based 
fashion with a pedometer in three chapters (figure 1). When looking at the variabiliy in daily 
physical activity level between these chapters, we should take into account that the disease 
severity differs between the chapters; Chapter 3 focusses on a broad range of patients with 








an outpatient clinic; and chapter 5 focusses on very severe COPD patients awaiting a lung 
transplantation.
Figure 1. Steps/day in patients with COPD measured with a pedometer in this thesis.
In chapter 3 the mean number of steps/day was 4762±2871 for the total group, 5603±2829 
for the primary care group, 5302±3203 for the secondary care group and 3656±2256 for the 
pulmonary rehabilitation group (data not shown in this thesis). In chapter 4 the mean number 
of steps/day of patients in secondary care was 7360±3951. In chapter 5 the mean number of 
steps/day of patients with COPD awaiting lung transplantation was 1407 ± 1.166.
Disease severity is not the only determinant of the observed large variability in daily physical 
activity level. From epidemiological studies it is well known that a large range in the daily physical 
activity level is quite usual in healthy as well as diseased subjects, even after adjusting for age 
and sex (1-3).
The level of daily physical activity is an important indicator of overall physical and psychosocial 
health and fitness (4). Recommendations for healthy adults are to walk 10.000 steps per day. 
In this thesis, the level of daily physical activity in COPD does not reach the recommendation of 
10.000 steps a day. Tudor-Locke and Myers (5) suggest that older adults and those living with 
a chronic disease could take 3500-5500 steps/day. This is in line with our results, except in the 
very severe COPD patients awaiting lung transplantation (chapter 5).
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When systematically reviewing the literature, we could compare the level of daily physical 
activity between patients with COPD and healthy adults. The level of daily physical activity 
of patients with COPD is significantly diminished compared to healthy controls: about fifty-
seven percent of that of healthy age-matched controls in performance-based studies, and about 
seventy percent in questionnaire-based studies.
The observation of the systematic review that daily physical activity level in COPD is higher when 
measured with a questionnaire was also seen in our questionnaire based studies. In chapter 5 
and 7 the level of daily physical activity seems relatively high for patients with COPD, especially 
in the severe COPD patients awaiting lung transplantation in chapter 5 . This observation could 
be explained by the differences between the instruments; questionnaires measure a broad range 
of physical activities, including upper extremity activities, that are not registered by performance 
based tools like light work and light household work. Besides, patients with COPD might be very 
well aware of accomplishing small routine daily activities, and therefore might overestimate their 
time spent on physical activities. This awareness of low impact activities might increase when 
the severity of the disease increases.
An advantage of using a questionnaire in measuring daily physical activity is that more insight 
is provided in the types of physical activity that patients with COPD perform. An interesting 
observation of chapter 2 is that males and females withdraw their activities in a different 
order. Females tend to hold on to household activities as long as possible, and experience 
more difficulty in performing home management tasks and hobbies. This could implicate that 
males and females should be treated in a different way when they participate in a physical 
enhancement or pulmonary rehabilitation program.
Daily physical activity is an important outcome measure in pulmonary patients. Although daily 
physical activity is increasingly studied in COPD, we believe it should be measured routinely 
in the general management of COPD, and of course in observational and intervention studies 
as well. In order to measure daily physical activity routinely, the methods of measuring and 
reporting daily physical activity in COPD should be standardized. In this thesis we have shown 
that there is a large difference in the level of daily physical activity when measured with 
performance based tools compared to questionnaire based tools. We have also shown that both 
measurement tools have advantages and disadvantages. The level of daily physical activity is best 
assessed in a performance based way. Questionnaires could provide us with more information 
about the types of physical activity. Both outcomes are relevant for the prevention or treatment 
of physical inactivity. Performance based instruments and questionnaires thus provide different, 
yet complementary information. Future studies should not only focus on the standardization of 








Enhancing daily physical activity
A low physical activity level in patients with COPD may lead to a downward spiral of inactivity 
leading to deconditioning and a reduction in health-related quality of life. Interventions to 
reverse the downward spiral of inactivity can be primarily targeted at increasing physical 
activities, theoretically followed by improvements of physical fitness. The usefulness of such a 
strategy is suggested by a meta-analysis of Chavannes, which included five studies that targeted 
physical activities like walking, cycling, swimming and/or training of large muscle groups (6). Since 
there are no current guidelines for the enhancement of physical activity in COPD, and since 
we demonstrated that there was a large variability in level of daily physical activity in patients 
with COPD, one specific guideline might not be feasible; the enhancement of physical activity 
in patients with COPD might require an individualized or tailored approach.
In chapter 4 we have shown that a combination of individual exercise counseling and pedometer 
monitoring is feasible and effective to enhance daily physical activity in a subgroup of patients 
with COPD. Daily physical activity, physical fitness, health-related quality of life and intrinsic 
motivation improved statistically significantly after the 12 weeks of intervention. The long term 
effects of the pedometer-based exercise counseling strategy were studied in a broader range of 
patients with COPD (7). This study showed that the level of physical activity was still increased 
15 months after the intervention for patients who were not sufficiently active at baseline (7). 
The study concluded that a pedometer-based exercise counseling can be implemented in a broad 
range of patients with COPD, but that there is a subgroup of patients with COPD who probably 
need the multidisciplinary approach of a pulmonary rehabilitation program.
The enhancement of daily physical activity in patients with COPD should ideally be implemented 
in the general management of COPD. When the daily physical activity level is routinely measured 
in patients with COPD, those patients with an inactive lifestyle could be invited to engage in 
an enhancement program. The pedometer based exercise counseling intervention could be an 
attractive program to implement in general management, since the program is not bound to take 
place on a specific location and can be adjusted individually. Future studies should focus on the 
effects and clinical relevance of the individual performance-based exercise counseling strategy, 
the combination with pulmonary rehabilitation in a subgroup of patients, and the feasibility to 
implement enhancement strategies into the general management of COPD.
Daily physical activity in patients with COPD after lung transplantation
Disease related factors diminishing the daily physical activity level are no longer fully present 
in patients with COPD who underwent a lung transplantation. During the first two years after 
lung transplantation there was a strong increase in daily physical activity level (cross sectional 
data, chapter 5), resulting in a daily physical activity level significantly above the daily physical 
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activity level of elderly and chronic diseased as determined by Tudor-Locke (8). Moreover, the 
daily physical activity level of lung transplant recipients corresponded with the level of a healthy 
population, in spite of their possible limitations (8).
In chapter 6 we showed that normal weight lung transplant recipients had a significantly higher 
level of daily physical activity as compared to overweight/obese lung transplant recipients. Since 
we could not find an association between overweight and food intake, we estimated that when 
overweight/obese lung transplant recipients would stick to their eating habits and would increase 
their number of steps per day to the level of normal weight lung transplant recipients, they could 
reach a normal BMI. This finding implicates that lung transplant recipients should be encouraged 
to enhance their physical activity level after lung transplantation. Post transplantation exercise 
programs are not routinely included in post transplantation care. Moreover, not much is known 
about the benefits of exercise programs after lung transplantation. Langer and colleagues 
studied the effects of exercise training after lung transplantation in a randomized controlled trial. 
Recipients in the intervention group achieved a higher level of physical activity, higher physical 
fitness, better self reported physical functioning, and reduced cardiovascular morbidity (9).
Our findings of high activity level in lung transplant patients, although based on cross sectional 
data, are promising for clinical practice. Longitudinal studies could provide more insight in the 
level of daily physical activity and its association with the development of (severe) overweight. 
Moreover, more insight is needed in the optimal way to increase daily physical activity after lung 
transplantation; is it counselling on physical activity, exercising in a structured programme, or 
both; and how to organise this for lung transplant recipients living in a wide region.
Determinants of daily physical activity in COPD
Daily physical activity and functional determinants
A lower level of daily physical activity in patients with COPD is associated with a higher level 
of airway obstruction (chapter 2 and 3), a lower level of physical fitness (chapter 2, 3 and 4), 
and higher levels of systemic inflammation (chapter 2). Especially the relation between airflow 
obstruction and physical fitness assessed with the 6 minute walking distance test was considered 
strong. In chapter 2 it was demonstrated that lower daily physical activity level is related to 
higher levels of systemic inflammation. Systemic inflammation was not a determinant we have 
studied in other chapters. The relationship between systemic inflammation and daily physical 
activity has also been demonstrated in healthy subjects and other chronic diseases (4;10-12).
Daily physical activity level and psychosocial determinants
It remains unclear why some patients are relatively active, and others are not. These differences 








systematic review (chapter 2) we could not find consensus on the association between a higher 
level of daily physical activity and higher quality of life. We did find an association between higher 
daily physical activity and higher quality of life in chapter 4. When studying the association 
between daily physical activity and psychological variables such as anxiety, depression and 
self-efficacy in chapter 3, we have found that daily physical activity was positively associated 
with psychological factors, though only indirectly, via functional capacity.
The discrepancy between our studies regarding the association between daily physical activity 
and psychosocial factors is not a new finding. A previous systematic review on the effects of daily 
physical activity could not find a clear relation between daily physical activity and quality of life 
(6). In chapter 2 we have discussed a possible explanation for this discrepancy. We suggested 
that many patients with COPD during their slowly progressing disease may gradually accept 
their sedentary life style. This suggestion is in line with large cross-sectional studies which 
demonstrate that perceived quality of life remains quite high in many patients with COPD, even 
in the more severe disease stages (13;14). The same cross-sectional studies also demonstrate an 
enormous range of quality of life scores within different disease stages of COPD; so it might be 
that a proportion of patients with COPD actually does not psychologically accept their disease 
state at all. In other words; there are acceptors and non-acceptors of reduced physical activity; 
which explains at least partly the inconsistency of findings in our studies and the studies in the 
literature. Studies focussing on this aspect of psychological adaptation are clearly needed
Determinants of daily physical activity in COPD patients after lung transplantation
The level of physical fitness remains diminished after lung transplantation. This was not a 
new finding, as it was previously shown by Reinsma and colleagues (15). In our study lower-
body strength, pulmonary function and number of months after transplantation contributed 
significantly to lower daily physical activity in COPD lung transplantation recipients. The 
influence of lower-body strength and airflow obstruction on daily physical activity was also 
shown in patients with COPD (chapter 2, 3 and 4). Physical activities that involve lower limbs 
are often avoided before lung transplantation causing muscle dysfunction (16-19). This pre-
existent muscle dysfunction may cause the large variation in lower-body strength within lung 
transplant recipients. This finding could implicate that maintaining the best possible lower body 
strength before lung transplantation, would benefit physical fitness and daily physical activity 
after lung transplantation.
Sleep quality and timing in relation to daily physical activity in obstructive airway disease
Sleep abnormalities are common in patients with obstructive airway diseases like COPD and 
asthma (20). In patients with COPD, we hypothesized that the timing of sleep could be shifted 
toward a later sleep timing due to disease factors such as experiencing sleep difficulties related 
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to sputum production and cough (21-23). Moreover, sleep timing could be shifted due to the 
smoking habits of patients with COPD, since smokers are more often late chronotypes (24-
26). The sleep timing was indeed significantly later in COPD as compared to an age- and sex-
matched general population. We could not find an association between sleep timing and disease 
severity defined by the level of airflow obstruction or the symptoms scale of the Saint George 
Respiratory Questionnaire.
In asthma patients we expected a shift towards earlier sleep timing in patients with nocturnal 
symptoms (cough, wheezing, chest tightness) as they may experience increased airway 
obstruction mostly between 3:00 and 6:00 AM (20). The sleep timing is significantly earlier 
in asthma patients as compared to an age- and sex-matched general population, but we could 
not associate this difference in sleep timing with the incidence of nocturnal complaints. Like in 
COPD smoking behavior was also an important factor in the sleep timing of asthma patients. 
The early sleep timing was significantly associated with non-smoking and being physically active 
in asthma patients.
The level of daily physical activity is significantly lower in patients with COPD as compared to 
asthma patients. Almost two-thirds of the asthma patients complied with the American College 
for Sports Medicine guideline of 30 minutes of moderate-intensity daily physical activity five 
days a week. In COPD, not even half of the patients with COPD complied with the American 
College for Sports Medicine guideline. When comparing asthma and COPD patients, we 
need to take into account that the asthma group is younger than the COPD group. Important 
significant contributors to the difference in the level of daily physical activity in the asthma and 
COPD group are age, smoking and the disease (asthma or COPD) (p≤.001, p≤.05 and p≤.001 
respectively; data not shown). Most daily physical activities are performed outside, like walking. 
The amount of time spent outdoors in broad daylight significantly affects the timing of sleep in all 
chronotypes; the longer the exposure to outdoor light, the more advanced the sleep period (27).
We did not measure the amount of time spent outdoors, so we can only speculate whether the 
amount of daylight is responsible for the different sleep timings of asthma and COPD patients.
In Chapter 7 we measured sleep timing using a questionnaire and nocturnal awakening by asking 
whether patients experienced nocturnal or early awakening due to disease specific factors. We 
did not measure the frequency and duration of nightly awakenings. It would be interesting to 
measure whether people get out of bed and expose themselves to light in the night, since light 
exposure is a very important determinant of sleep timing (27). The frequency and duration of 
nightly awakenings would most likely have an effect on sleep quality and feeling fit during the 
day. One could hypothesize that feeling tired during the day has an influence on the physical 








influence of physical activity on sleep timing and sleep quality in COPD and asthma need further 
investigation, as it might provide important insight for strategies to improve the sleep quality 
and overall quality of life in patients with obstructive airway diseases.
Next to sleep timing and nocturnal awakening, daily physical activity level in COPD and asthma 
patients was also assessed in a questionnaire based fashion. In Chapter 2 we have concluded that 
when using a questionnaire patients with COPD might overestimate their physical activities and 
that a performance based tool could provide a more precise insight in the level of daily physical 
activity in patients with COPD. Future studies should incorporate the performance based daily 
physical activity, measurement of sleep timing and nocturnal awakening. The DynaPort MiniMod 
could be a useful device in these studies, since we showed that it is a valid and feasible device 
in measuring changes of body position and physical activity during the night (chapter 8) next to 
measuring physical activities during the day.
FUTURE PERSPECTIVES
This thesis has reviewed and studied daily physical activity in pulmonary patients. The findings, 
mostly based on cross sectional data, are promising for clinical practice. Future studies should 
focus on:
- the optimal combination of different daily physical activity assessment tools, and how to 
standardize this
- using longitudinal studies to better understand potential causes and consequences of 
physical activity level
- long term effects of daily physical activity enhancement programs in COPD
- the integration of daily physical activity enhancement and exercise programs after lung 
transplantation
- the underlying mechanisms (and targets for intervention) that contribute to overweight and 
obesity after lung transplantation
- performance based assessment of daily physical activity, sleep timing, nocturnal awakening 
and light exposure
We strongly believe that daily physical activity is an important outcome measure in COPD 
management. By improving our knowledge about daily physical activity, its determinants and the 
enhancement of daily physical activity we can hopefully slow down the downward spiral of immobility 
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Ziek zijn gaat vaak samen met ‘even rustig aan doen’. Plat op de bank en volledig in de watten 
gelegd worden. Het zit er bij ons ingebakken, als je ziek bent doe je rustig aan. Aan de andere kant 
ontlast en verzorg je iemand die ziek is. Maar hoe moet dat als iemand chronisch – altijd - ziek is?
COPD
Dit proefschrift gaat over dagelijkse fysieke activiteiten bij mensen met een chronische 
longafwijking, voornamelijk mensen met COPD. COPD staat voor ‘Chronic Obstructive 
Pulmonary Disease’, oftewel chronisch obstructief longlijden in het Nederlands. COPD is een 
chronische longaandoening die gekenmerkt wordt door onomkeerbare luchtwegvernauwing, die 
wordt veroorzaakt door een abnormale ontstekingsreactie van de longen op rook en schadelijke 
deeltjes. Deze ontstekingsreactie leidt ertoe dat de longfunctie progressief achteruit gaat. Het 
achteruitgaan van de luchtwegvernauwing is niet of nauwelijks op te heffen door medicijnen. 
De voornaamste symptomen van COPD zijn kortademigheid, hoesten, slijmproductie en 
een verminderd inspanningsvermogen. COPD heeft niet alleen effect op de longen; het kan 
daarnaast ook leiden tot (over)vermoeidheid, verminderde spierkracht, gewichtsverlies en een 
verminderde kwaliteit van leven. Daarnaast komen co-morbiditeiten als een hoge bloeddruk, 
suikerziekte en neerslachtigheid vaker voor bij mensen met COPD in vergelijking met mensen 
zonder COPD. COPD is niet te genezen. De behandeling van COPD richt zich op stoppen 
met roken, medicatie, zuurstoftherapie, revalidatie en chirurgische behandeling. In de huidige 
COPD richtlijnen wordt daarnaast ook dagelijkse fysieke activiteit aangeraden voor alle COPD 
patiënten.
Wat bedoelen we met dagelijkse fysieke activiteiten?
Dagelijkse fysieke activiteiten zijn alle bewegingen in het alledaagse leven, zoals wandelen, 
fietsen, werken en sporten. De officiële definitie is ‘elke krachtinspanning van skeletspieren 
die resulteert in meer energieverbruik dan in rust’ (1). Dagelijkse fysieke activiteiten geven 
weer wat iemand daadwerkelijk doet, en dat is verschillend van wat iemand kan. Dit laatste 
wordt uitgedrukt als fitheid of inspanningsvermogen. Regelmatig fysiek actief zijn heeft grote 
gezondheidsvoordelen: het draagt bij aan algemene fysieke en psychosociale gezondheid en 
draagt bij aan het voorkomen van verschillende chronische ziekten zoals hart- en vaatziekten en 
diabetes type 2 (2). Een derde van de volwassenen wereldwijd is inactief (1). Om te voldoen aan 
de richtlijn voor gezond bewegen hoef je overigens niet elke dag naar de sportschool. De richtlijn 
voor gezond bewegen is tenminste 5 dagen per week 30 minuten op matige intensiteit fysiek 
actief zijn, of 3 dagen per week 20 minuten hoge intensiteit actief zijn, of een combinatie hiervan 
(3). Onder matige fysieke activiteit verstaan we activiteiten waarbij de ademhaling omhoog 
gaat, we het warmer krijgen en ons hart sneller gaat kloppen, zoals bijvoorbeeld bij lopen of 
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fietsen het geval is. De richtlijn voor gezond bewegen is opgesteld voor gezonde volwassenen 
en mogelijk niet goed toepasbaar voor chronisch zieken. Het wordt aangeraden om de intensiteit 
voor chronisch zieken aan te passen aan het niveau van individuele fitheid. Hiervoor ontbreekt 
echter een eenduidige richtlijn (4).
Waar hebben we naar gekeken in dit proefschrift?
Ondanks dat COPD veel voor komt, is er weinig bekend over het dagelijkse fysieke activiteiten 
niveau van COPD patienten. Nog minder is bekend over de mogelijke factoren die bijdragen 
aan het dagelijkse fysieke activiteiten niveau, en de gevolgen voor de kwaliteit van leven. Deze 
informatie is zeer belangrijk bij het ontwerpen van programma’s die de voor COPD bekende 
vicieuze cirkel van benauwdheid > minder bewegen > conditie verlies > depressie > sociale 
isolatie > nog minder bewegen, moeten voorkomen of doorbreken.
Dagelijkse fysieke activiteiten niveau bij COPD
In dit proefschrift hebben we allereerst een overzicht gemaakt van wat er tot nu toe in de 
literatuur bekend is over dagelijkse fysieke activiteiten bij COPD (hoofdstuk 2). In de literatuur 
vonden we de bevestiging van wat we eigenlijk al wisten: COPD patiënten hebben een lager 
niveau en lagere intensiteit van bewegen vergeleken met gezonde personen. Het dagelijkse 
fysieke activiteiten niveau van COPD patiënten is ook lager dan dat de richtlijnen aanraden 
voor het behouden of verbeteren van fysieke gezondheid en fitheid.
We vonden ook een aantal zaken in de literatuur die we nog niet wisten. Er is een opvallend 
verschil tussen de uitkomsten gemeten met de verschillende meet instrumenten, een 
activiteitenmonitor of met een vragenlijst. Een activiteiten monitor meet precies wat je doet. 
Een vragenlijst is iemands eigen inschatting van de hoeveelheid van zijn/haar fysieke activiteiten. 
Wanneer je met een vragenlijst meet hoeveel iemand beweegt, geeft dat een hogere uitkomst en 
minder verschil met gezonde mensen dan wanneer gemeten wordt met een activiteitenmonitor. 
We vermoeden dat mensen met COPD zich heel erg bewust zijn van de kleinere dagelijkse 
fysieke activiteiten en inspanningen – veel meer dan gezonde mensen – waardoor het dagelijkse 
fysieke activiteiten niveau hoger wordt ervaren en weergegeven.
Een andere interessante bevinding in de literatuur was dat er een verschil lijkt te zijn tussen 
mannen en vrouwen in de volgorde van het staken van bepaalde dagelijkse fysieke activiteiten, 
waarbij vrouwen zo lang mogelijk vast houden aan het blijven uitvoeren van huishoudelijke taken. 
Dit zou een aanleiding kunnen zijn om mannen en vrouwen op een andere manier te benaderen 









In dit proefschrift hebben we in 3 hoofdstukken bij COPD patiënten activiteiten gemeten 
met een stappenteller. Een stappenteller is een klein apparaatje wat aan de broekrand wordt 
gedragen en nauwkeurig het aantal stappen meet wat iemand zet. We zien in deze drie 
hoofstukken een groot verschil in het aantal stappen wat COPD patiënten zetten, vergelijkbaar 
met de literatuur.
 
Figuur 1. Het aantal stappen per dag gemeten met een stappenteller in dit proefschrift.
Hierbij moeten we ook rekening houden met het verschil in de mate waarin de ziekte is 
gevorderd tussen de verschillende hoofdstukken, waarbij in hoofdstuk 3 een hele brede groep 
COPD patiënten is bestudeerd, in hoofdstuk 4 patiënten die bij de longarts onder behandeling 
zijn, en in hoofdstuk 5 COPD patiënten die in een ver gevorderd stadium van de ziekte verkeren 
en wachten op een longtransplantatie.
De mate waarin de ziekte is gevorderd is niet de enige verklaring voor de verschillen in het 
dagelijkse fysieke activiteiten niveau. Het is bekend dat er bij gezonde mensen ook een grote 
verscheidenheid is in het dagelijkse fysieke activiteiten niveau (5-6).
Wat zorgt er voor dat iemand wel/niet actief is?
Het blijft onduidelijk waarom iemand wel of niet fysiek actief is, ook in dit proefschrift. Het 
lagere dagelijkse fysieke activiteiten niveau van COPD patiënten in dit proefschrift is met name 
geassocieerd met een sterkere mate van luchtwegvernauwing en een lager niveau van fysieke 
fitheid. De associatie tussen het dagelijkse fysieke activiteiten niveau en de kwaliteit van leven 
is minder duidelijk en verschilt in dit proefschrift ook tussen de verschillende hoofdstukken. 
In hoofdstuk 3 is de relatie met psychosociale factoren, zoals angst en depressie, uitgebreid 
bekeken. Hierbij hebben we gezien dat de relatie tussen het dagelijkse fysieke activiteiten niveau 
en psychosociale factoren indirect is. Deze onduidelijkheden geven aanleiding voor verder 
171
onderzoek. Wanneer we goed weten waardoor het komt dat iemand wel of niet fysiek actief is, 
kunnen we dit namelijk gebruiken in het stimuleren van dagelijkse fysieke activiteiten.
Hoe kunnen we ervoor zorgen dat mensen met COPD weer fysiek actiever worden?
Aangezien er geen richtlijn is voor gezond bewegen specifiek voor COPD patiënten, en er grote 
verschillen bestaan tussen het dagelijkse fysieke activiteiten niveau van COPD patiënten in de 
verschillende fase van de ziekte vordering, is voor de stimulatie van bewegen waarschijnlijk een 
individuele aanpak nodig. In hoofdstuk 4 hebben we bekeken of een combinatie van individuele 
coaching op activiteiten en het gebruik van een stappenteller een goede methode is om COPD 
patiënten te stimuleren om te bewegen. Zoals eerder aangegeven kan het dagelijkse fysieke 
activiteiten niveau naast in tijd en intensiteit ook weergegeven worden in het aantal stappen 
per dag. De richtlijn voor gezonde volwassenen is om 10.000 stappen per dag te zetten (7). 
Een stappenteller is daarbij een handig instrument waarmee het aantal stappen wordt geteld. 
Doordat je de hele dag door kan zien hoeveel stappen er gezet zijn, kan de stappenteller 
motiverend werken. Dit werkt nog beter wanneer er een (individueel) doel wordt gesteld 
aan het aantal stappen per dag (8). Het stellen van individuele doelen vond plaats in de 
coachingsgesprekken, waarbij gebruik werd gemaakt van een aantal bewezen technieken zoals 
specifieke doelen stellen en motiverende interview technieken. In deze studie zijn de deelnemers 
verdeeld over twee groepen. De eerste groep kreeg 5 individuele coachingsgesprekken en droeg 
12 weken de stappenteller. De tweede groep droeg alleen de stappenteller zonder specifieke 
richtlijnen. Na 12 weken bewegen mensen in de coaching groep meer dan voorafgaand aan de 
studie. Ze bewegen ook meer in vergelijking met de groep die alleen de stappenteller droeg. 
Niet alleen verbeterde het aantal stappen per dag, ook verbeterde de armkracht, beenkracht, 
kwaliteit van leven en de intrinsieke motivatie om actief te zijn in de coaching groep. Dit is een 
veelbelovend resultaat.
De stimulatie om fysiek actief te zijn zou eigenlijk altijd een vast onderdeel moeten zijn in de 
algemene behandeling/begeleiding van COPD patiënten. Wanneer het dagelijkse fysieke 
activiteiten niveau op routine basis wordt gemeten bij COPD patiënten kunnen inactieve 
patiënten worden uitgenodigd om deel te nemen aan een stimuleringsprogramma. De individuele 
coaching op activiteiten met behulp van de stappenteller lijkt hiervoor zeer geschikt. Naast de 
positieve resultaten die we zien in Hoofdstuk 4, is de coaching niet gebonden aan een specifieke 
locatie en kan die individueel aangepast worden. Vervolg studies zijn nodig om de effecten op 
lange termijn en de toepasbaarheid van de individuele coaching op activiteiten met behulp van 









Als je de ziekte ‘wegneemt’, hoe gaat het dan met de fysieke activiteiten?
Een zeer ingrijpende behandelmogelijkheid voor mensen met zeer ernstige COPD is een 
longtransplantatie. Een longtransplantatie is een operatie waarbij een of twee zieke longen 
worden vervangen door gezonde longen van een donor. In hoofdstuk 5 hebben we gekeken naar 
het dagelijkse fysieke activiteitenniveau van patiënten voor en patiënten na longtransplantatie. 
In de eerste twee jaar na de transplantatie is er een sterke stijging in het dagelijkse fysieke 
activiteitenniveau. Opvallend is dat patiënten twee jaar na een longtransplantatie op een 
gemiddeld dagelijks fysieke activiteitenniveau zitten wat boven het gemiddelde van zieken en 
ouderen uitkomt. Sterker nog, het dagelijkse fysieke activiteitenniveau na longtransplantatie is 
gelijk aan dat van gezonde mensen (7). Dit is verwonderlijk, zeker omdat de fysieke fitheid na 
longtransplantatie niet geheel herstelt.
Ongeveer 30% van de longtransplantatie patiënten ontwikkelt overgewicht of zelfs obesitas. 
In hoofdstuk 6 hebben we gekeken naar de factoren die mogelijk bijdragen aan deze (forse) 
gewichtstoename. We zien dat longtransplantatie patiënten met een normaal gewicht significant 
meer bewegen dan longtransplantatie patiënten met overgewicht of obesitas. Opvallend genoeg 
konden we geen verschil vinden tussen de voedingspatronen van patiënten met een gezond 
gewicht en overgewicht of obesitas. Het grote verschil in het dagelijkse fysieke activiteitenniveau 
tussen longtransplantatie patiënten met een normaal gewicht versus de patiënten met 
overgewicht of obesitas geeft aanleiding om patiënten na longtransplantatie te stimuleren om 
een relatief hoog niveau van dagelijkse fysieke activiteiten aan te nemen om te voorkomen dat 
ze overgewicht of zelfs obesitas ontwikkelen.
Bewegingsprogramma’s werden bij het uitvoeren van het onderzoek niet standaard aangeboden 
na longtransplantatie. Er zijn ook geen specifieke richtlijnen voor het dagelijkse fysieke 
activiteiten niveau na longtransplantatie. Onze bevindingen geven aanleiding om dit verder te 
onderzoeken. Daarbij is het ook belangrijk om te kijken wat dan de beste manier is om patiënten 
na longtransplantatie te stimuleren om (meer) te bewegen; is dat via individuele coaching op 
activiteiten, zoals we in hoofdstuk 4 hebben bekeken, of op een andere manier?
Is er een relatie met de timing van slaap?
Toenemende last van luchtwegklachten in de nacht en vroege ochtend is een veelvoorkomende 
klacht bij COPD- en astmapatiënten. Dit zou kunnen leiden tot een verandering in het 
slaapwaakritme; het tijdstip van naar bed gaan en opstaan, oftewel de timing van slaap. Ook 
kunnen verstoringen tijdens de nacht zorgen voor vermoeidheid overdag en mogelijk daardoor 
ook een lager dagelijkse fysieke activiteitenniveau. In hoofdstuk 7 hebben we gekeken naar 
de timing van slaap bij COPD en astma patiënten. We hebben een grote groep COPD- en 
astmapatiënten die de afdeling longziekten van het UMCG bezoeken vragenlijsten opgestuurd. 
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Deze vragenlijsten gingen over de timing van slaap, bewegen, kwaliteit van leven en over roken 
en nachtelijk ontwaken. De uitkomsten hebben we vergeleken met een algemene populatie.
Bij astma patiënten verwachtten we een vroege slaaptiming doordat astma patiënten vaak 
nachtelijke klachten ervaren zoals hoesten en kortademigheid, meestal tussen 3 en 6 uur ’s 
nachts (9). De timing van slaap is inderdaad vroeger bij mensen met astma vergeleken met de 
controlegroep in deze studie. Deze vroegere timing is geassocieerd met niet roken en fysiek 
actief zijn. De meeste astmapatiënten zijn fysiek actief en voldoen aan de richtlijnen voor gezond 
bewegen. Opvallend genoeg konden we geen relatie vinden tussen de timing van slaap en het 
nachtelijk (of zeer vroeg) wakker worden.
Bij COPD patiënten verwachtten we een latere slaaptiming door ziekte gerelateerde klachten als 
slijmvorming en hoesten (10-12). Daarnaast verwachtten we dat roken mogelijk een rol speelt bij 
de timing van slaap. COPD is een rookgerelateerde ziekte en uit de literatuur over slaaptiming 
is bekend dat mensen die roken vaker een latere slaaptiming hebben (13-15). COPD patiënten 
hebben inderdaad een latere slaaptiming in vergelijking met de controlegroep in deze studie. 
Deze late timing blijkt ook in onze groep inderdaad geassocieerd met roken. In de COPD groep 
kunnen we geen associatie vinden tussen de timing van slaap en (nachtelijke) COPD klachten. 
Bij COPD patiënten vinden we geen relatie tussen de timing van slaap en al dan niet fysiek actief 
zijn. In deze studie voldoet 49% van de COPD patiënten aan de richtlijn voor gezond bewegen.
Dagelijkse fysieke activiteiten zijn in dit hoofdstuk gemeten met een vragenlijst, evenals het 
nachtelijke wakker worden. Niet alleen de bewegingen overdag, maar ook de bewegingen 
gedurende de nacht kunnen met een activiteiten monitor worden gemeten. In hoofdstuk 8 
hebben we aangetoond dat de DynaPort MiniMod een goed meetinstrument is om bewegingen 
in bed en fysieke activiteit gedurende de dag te meten. In hoofdstuk 7 hebben we alleen gekeken 
of iemand nachtelijke klachten heeft. We weten niet hoe vaak en hoe lang deze verstoringen 
gedurende de nacht optreden. Met een activiteiten monitor zouden we niet alleen kunnen meten 
hoe vaak iemand gedurende de nacht wakker wordt, maar ook of iemand uit bed gaat. Mogelijk 
geeft dit een andere uitkomst wanneer we kijken naar de relatie tussen verstoringen tijdens de 
nacht en het dagelijkse fysieke activiteiten niveau overdag.
Hoe kunnen we dagelijkse fysieke activiteit het beste meten?
In dit proefschrift zien we grote verschillen tussen het dagelijkse fysieke activiteiten niveau 
van mensen met COPD, zelfs wanneer het wordt gemeten met het zelfde meetinstrument. 
Als we meer willen weten over dagelijkse fysieke activiteiten bij COPD moeten we ons eerst 
richten op de optimale manier van meten. Activiteiten monitors geven het beste weer wat het 









nuttige informatie over welke dagelijkse fysieke activiteiten worden gedaan. Beide uitkomsten 
zijn relevant voor het voorkomen of behandelen van fysieke inactiviteit. Vervolgstudies zouden 
daarom niet alleen moeten inzetten op de optimalisatie van het meten van dagelijkse fysieke 
activiteiten, maar ook op de optimale combinatie van meetinstrumenten.
In dit proefschrift zien we dat het dagelijkse fysieke activiteiten niveau van COPD patiënten 
laag is. We zien ook dat we dagelijkse fysieke activiteiten kunnen stimuleren, en dat deze 
stimulatie een positief effect heeft. We zijn er van overtuigd dat aandacht voor dagelijkse 
fysieke activiteiten belangrijk is bij COPD patiënten. Door onze kennis over dagelijkse fysieke 
activiteiten en de factoren die hieraan bijdragen in te zetten kunnen we hopelijk de neerwaartse 
spiraal waarin COPD patiënten dreigen terecht te komen afremmen. Misschien kunnen we 
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Mijn grootste dank gaat uit naar de deelnemers aan de studies beschreven in dit proefschrift. 
En dat zijn er nogal wat: bij elkaar opgeteld hebben er 874 deelnemers meegewerkt. Ik vind dat 
waanzinnig. Heel veel dank daarvoor.  
Veel dank gaat uit naar mijn promotor Prof. dr. H.A.M. Kerstjens, eerste co-promotor en dagelijks 
begeleider Dr. N.H.T. ten Hacken en co-promotoren Dr. M.H.G. de Greef en Dr. J.B. Wempe.
Beste Huib, tijdens het onderzoekstraject vervulde je een rol op de achtergrond. Jouw rol bij 
de uiteindelijke totstandkoming van dit proefschrift is des te groter. Ik heb onze overleggen 
altijd als enorm inspirerend, energievol en opbeurend ervaren. Na zo’n overleg had ik weer de 
energie en de moed om er tegen aan te gaan. Dank voor het snelle schakelen in de laatste fase, 
de bemoedigende woorden en bovenal dank dat ik na al die tijd nog mag promoveren :) 
Beste Nick, je enthousiasme en interesse voor het onderzoek en met name de discussies 
eromheen zijn inspirerend. Je hebt me enorm veel geleerd:  kritisch en out-of-the-box denken, 
schrijven (zoals Mimi) en discussiëren. Vooral dat laatste hebben we veel gedaan. We kunnen 
het aardig met elkaar oneens zijn, maar onze discussies eindigden vaak in mooie dingen. En ook 
al zakte de moed me af en toe behoorlijk in de schoenen als er weer een stuk vol opmerkingen 
terugkwam, dit proefschrift was er absoluut niet geweest zonder jou. We hebben, samen met 
Mathieu, mooie uitstapjes gemaakt buiten het proefschrift. Het is jammer dat het niet wat 
geworden is met onze feetb@ck pedometer. Wat was het mooi geweest om stroomstoten uit 
te delen bij inactiviteit. De laatste loodjes duurde in mijn geval enorm lang. Dank dat je me niet 
hebt opgegeven, dank voor het ‘we zijn er bijna’ teken, dank voor het vertrouwen maar bovenal 
dank voor alles wat je me geleerd hebt. 
Beste Mathieu, je hebt me enthousiast gemaakt voor het onderzoek. Mijn afstudeeronderzoek 
met jou als begeleider was mijn eerste stap in de onderzoekswereld. Je optimisme en 
enthousiasme zijn van onschatbare waarde. Evenals je hulp bij de analyses. Ik heb het altijd 
erg naar mijn zin gehad bij jou op de kamer. Ik heb enorm veel geleerd van het ‘afluisteren van 
gesprekken’ met studenten. Bedankt voor alles. 
Beste Johan, dank voor de met name praktische ondersteuning bij het onderzoek, zowel op 
Beatrixoord als in de contacten met de long- en huisartsen. Ik denk met plezier terug aan de 
lunches op Beatrixoord, waarbij een verscheidenheid aan vermakelijke gesprekken door mijn 
hoofd gaan; van hoofdluis tot psychologische interventies met collega’s tot de wat serieuzere 
onderzoeksgerelateerde onderwerpen. 
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Graag wil ik de leescommissie bestaande uit Prof. dr. R. Sanderman, Prof. dr. M.A. Spruit en 
Prof. dr. C.P. van der Schans zeer bedanken voor hun bereidheid dit proefschrift te lezen en te 
beoordelen. 
Dank aan de sponsoren van de verschillende onderzoeken in dit proefschrift: Boehringer 
Ingelheim en Het Universitair Medisch Centrum Groningen. Dank aan McRoberts voor het 
gebruiken van de DynaPort MiniMod en de ondersteuning bij het uitlezen van de data. 
Ik wil alle medeauteurs bedanken voor hun bijdrage aan de verschillende mooie onderzoeken 
en bovenal voor de ondersteuning bij het schrijven. Wim Krijnen, voor de ondersteuning met de 
soms behoorlijk ingewikkelde statistiek, die je uiterst duidelijk kon uitleggen. Wytske Altenburg 
en Gieneke Hospes, ik heb ontzettend veel geleerd van onze samenwerking op het COACH 
onderzoek, welke begon met Gieneke en eindigde met Wytske. Dank dat ik een rol er tussenin 
mocht spelen. Peter van Hengel, voor de ondersteuning bij de totstandkoming van de COACH 
pilotstudie in Assen. Gerard Koëter, mijn stagebegeleider tijdens mijn afstudeerproject en het 
eigenlijke begin van dit proefschrift, bedankt voor de eerste stappen en de introductie binnen 
de longziekten. Wim van der Bij en Erik Verschuuren, ik heb het zo naar mijn zin gehad bij jullie 
op de afdeling. Ik kijk met veel plezier terug op de longtransplantatie onderzoeken en ik wil jullie 
bedanken dat de deur altijd open is blijven staan. Marjolein den Ouden en Rob Douma, voor 
de enorme inzet en ondersteuning bij het onderzoek naar overgewicht na longtransplantatie. 
Dirkje Postma, Erika van der Wiel en chronobiologen Marijke Gordijn, Martha Merrow en Till 
Roenneberg, bedankt voor de ondersteuning en het beschikbaar stellen van de aanvullende 
en controle data van hoofdstuk 7. Daarnaast dank aan de stille krachten achter hoofdstuk 
7; Jeroen Kregel en Amarens Proce, voor hun hulp bij het verzamelen en verwerken van de 
data. En tenslotte, Nienke Kosse en Johannes van der Hoeven, voor de uitvoering van en de 
ondersteuning bij de polysomnografie en actografie onderzoeken. 
Alle mensen werkzaam bij de secretariaten Longtransplantatie, Longziekten en Longrevalidatie 
Beatrixoord, en in het bijzonder Willie en Trudy, veel dank voor de praktische ondersteuning, 
de gezelligheid en de hulp bij het plannen van afspraken met zowel mijn (co)promotoren als met 
patiënten. Dank aan de fysiotherapeuten van Beatrixoord en longfunctieassistenten van het 
UMCG en Beatrixoord voor de praktische ondersteuning bij de verschillende onderzoeken. 
Dank aan het GRIAC. Tijdens mijn allereerste ontmoeting met het GRIAC mocht ik op uitnodiging 
van Nick een presentatie geven over mijn afstudeeronderzoek. Als ik had geweten hoe (positief) 
kritisch deze groep was én dat het in het Engels moest worden gepresenteerd, dan had ik nooit 
naar binnen durven gaan. Ik heb ontzettend veel geleerd van presentaties over uiteenlopende 









Dank aan mijn kamergenoten en medeonderzoekers. Het zijn er over de jaren heen en op 
verschillende afdelingen heel wat geweest. Met name dank aan Joost, Cornelis, Rob, Joanne, 
Wouter en Rianne van Bewegingswetenschappen en Judith, Wouter, Naomi, Renske, Jan Willem, 
Marieke, Fransien, Anda, Wytske en Jorine van de afdeling Longziekten. Ik kijk met veel plezier 
terug naar de praatjes bij het koffie automaat, of door de kast met Joost en Cornelis, waar ik 
ook nog een keer met jullie hulp door ben gekropen omdat Mathieu me had ingesloten.., maar 
vooral ook de vrijdagmiddagborrels bij de Stadtlander en de dansjes achter de computer met 
Fransien. Wat heb ik die laatste twee gemist toen ik bij KWF ging werken ;) 
Ook dank aan mijn huidige collega’s. Ik heb zo veel geleerd bij KWF en ontzettend leuke en 
inspirerende mensen mogen ontmoeten. Het is een prachtig doel en helaas nog te hard nodig. 
In het bijzonder dank aan Merel. We zijn van begin af aan een bijzonder goed team geweest. 
We vulden elkaar perfect aan in het werk bij KWF en je bent daarnaast een zeer waardevolle 
vriendin geworden. Ik vind het fantastisch dat je als paranimf naast me staat op deze bijzondere 
dag!
Veel dank aan alle vriendinnen en vrienden. Met name Michaela, Anouk en Anne Loes voor 
de mooie Groningen- en daarna tijd. In het bijzonder dank aan Kim van Soest-Meijer voor de 
gezellige en welkome ont-en inspanning naast het onderzoek. Ik ben je ontzettend dankbaar 
voor alles. We sluiten hiermee een hoofdstuk af en ik vind het geweldig dat je dat samen met 
mij als paranimf doet! 
Een aparte alinea voor Kim Verbeeten-Sekreve. Al meer dan 30 jaar maken we elke grote stap, 
up en down, samen mee. Altijd positief, attent, vrolijk en enthousiast. Zo enthousiast dat je een 
keer de hele KLM crew van de vlucht naar San Francisco (waar het ATS congres was) voor me 
hebt laten klappen omdat ik een travel award had gekregen. Dank voor alles.  
Mijn familie en schoonfamilie, dank voor de steun en vooral het meejuichen bij de bijzondere 
momenten. In het bijzonder mijn ouders, zonder jullie was dit alles niet mogelijk. Dank voor 
jullie onvoorwaardelijke steun en vertrouwen en bovenal dank dat jullie er altijd voor ons zijn. 
Lieve Cato en Govert, de allermooiste titel heb ik van jullie gekregen. Ik geniet ontzettend veel 
van jullie. Ik kan niet trotser en gelukkiger zijn. 
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Liefste Bob, het was een drama onderwerp de afgelopen jaren. ‘Je boekje’ stond garant voor een 
flinke daling van mijn mondhoeken (op goede dagen…). Jouw enorme vertrouwen is misschien 
wel de belangrijkste reden dat ik het heb afgemaakt. Je hebt me het allermooiste gegeven en 
op 30 juni maakt de laatste titelwijziging het plaatje helemaal af. Wie had dit gedacht 10 jaar 
geleden. Ik kan niet wachten. Ik heb er zin in!
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